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Abstract 
 
HEATHER M. MARLOW:  Unwanted Fertility Experience, HIV Status and Post-partum 
Contraceptive Use in a PMTCT Population in Durban, South Africa 
(Under the direction of Dr. Siân Curtis) 
 
The HIV prevalence in South Africa is 17.1% and a majority of HIV infected adults 
are women.  One of the government’s strategies to avert new HIV infections is the prevention 
of unwanted pregnancies in HIV positive women through contraceptive use.  Therefore, 
understanding how unwanted fertility and HIV status affect contraceptive use is important to 
meeting this goal.  The purpose of this mixed methods dissertation is to understand how 
unwanted fertility experience, HIV status and health facility factors affect women’s 
contraceptive use in the post-partum period. The specific aims are:  Aim 1: To examine 
whether knowledge of HIV status affects women’s modern contraceptive use post-partum, 
Aim 2: To determine whether unwanted fertility and HIV status affect post-partum modern 
contraceptive use and intent and Aim 3: To explore health facility factors including client-
provider interactions around contraception, counselor’s knowledge about contraceptive 
methods, client waiting times and other health facility factors affecting modern contraceptive 
use post-partum. Quantitative methods were used for Aims 1 and 2 using a sample of 
sexually active post-partum women from an urban township outside of Durban, South Africa. 
Several multivariate logistic regression models were used to examine intent to use 
contraceptives at baseline and unwanted fertility experience, HIV status and post-partum 
contraceptive use at 14 weeks. Qualitative methods were used for Aim 3. In-depth interviews 
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were conducted with clients and providers to identify health facility factors influencing in 
post-partum contraceptive use. Results from the quantitative paper demonstrate that intent 
did not predict post-partum contraceptive use, HIV status had a direct, but not moderating, 
effect on post-partum contraceptive use and that women experiencing unwanted fertility were 
less likely to use contraceptives post-partum. The measure of unwanted fertility likely 
underestimated unwanted fertility experience in this population. Findings from the qualitative 
paper indicate areas where clinic contraceptive programs can improve post-partum 
contraceptive use.  Educating nurses about contraceptive initiation and more permanent 
methods, such as sterilization, could improve post-partum contraceptive use and reduce costs 
and patient overload. Creating opportunities for nurses and clients to have more in-depth 
discussions about contraceptive methods, side effects, condoms and STIs would improve 
post-partum contraceptive use. 
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Chapter 1:  Introduction 
 
The adult (ages 15-49) HIV prevalence in South Africa is 17.1% and a majority of 
HIV infected adults are women of childbearing age (1).  Strategies to prevent new HIV 
infections are needed to slow the spread of the disease.  One strategy endorsed by the World 
Health Organization (WHO) and implemented as part of South Africa’s Prevention of 
Mother to Child Transmission (PMTCT) program is the prevention of unwanted pregnancies 
in HIV positive women through the use of modern contraceptive methods (2).  Despite its 
potential to avert unwanted fertility and new infant HIV infections, there is little existing 
research examining how HIV status and unwanted fertility affect women’s adoption of 
modern contraceptive methods. There is even less research examining contraceptive use post-
partum to avoid future unwanted pregnancies and whether it varies depending on a woman’s 
HIV status. 
Research Questions: How does knowledge of HIV status affect women’s modern 
contraceptive use post-partum? How do knowledge of HIV status and unwanted fertility 
affect post-partum contraceptive use? What are health facility factors that affect women’s 
post-partum contraceptive use?  
Specific Aim 1: To examine whether knowledge of HIV status affects women’s 
modern contraceptive use post-partum. Hypothesis 1: Women who intend to use modern 
contraceptives post-partum and test HIV positive are more likely to use contraceptives post-
partum than women who intend to use contraception post-partum and test HIV negative. 
Hypothesis 2: Women who test HIV positive are more likely to self-report condom use and 
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dual protection (use of a barrier method and hormonal method) post-partum compared to 
women who test HIV negative.  
Specific Aim 2: To determine whether unwanted fertility and HIV status affect post-
partum modern contraceptive use and intent. Hypothesis 3: Women who have experienced 
unwanted fertility are more likely to report intent to use contraceptives in the future than 
women who have not experienced unwanted fertility. Hypothesis 4: Women who have 
experienced unwanted fertility and test HIV positive are more likely to self-report current 
modern contraceptive use than women who have experienced unwanted fertility and who test 
HIV negative.  
Specific Aim 3: To explore health facility factors, including but not limited to: client-
provider interactions around contraception, the points during antenatal care when women 
discuss contraception with providers, contraceptive counselor’s level of knowledge about 
contraceptive methods, the contraceptive method mix available in the clinic, client waiting 
times and other health facility factors influencing women’s use of modern contraception 
post-partum.  
 
 
 
 
 
 
 
  
 
Chapter 2:  Background 
 
HIV/AIDS in South Africa 
 
The HIV/AIDS epidemic is devastating South Africa and there is an urgent need to 
identify new strategies to slow the spread of the disease and prevent new HIV infections. The 
epidemic in South Africa is one of the fastest growing in the world (3). The adult (ages 15-
49) HIV prevalence of 17.1% is one of the highest in the world, and South Africa is home to 
the largest population of HIV infected persons worldwide (5.6 million) (1).  AIDS is the 
leading cause of death in South Africa and HIV/AIDS accounts for 31% of disability 
adjusted life years (4, 5). Without effective interventions to slow the spread of HIV and treat 
AIDS infected South Africans, the demographic effect on the population will be catastrophic. 
Women in their childbearing years are most affected by the HIV epidemic in South 
Africa. Fifty nine percent of HIV infected adults over the age of 15 are women in their 
childbearing years and most women are infected with HIV before the age of 25 (6, 7). Futher, 
HIV infections in pregnant women have increased from 1% in 1990 to 30% in 2005 (8). 
Effective interventions to prevent HIV infections in women of childbearing age and pregnant 
women are critically needed in South Africa. The benefits of preventing HIV infections or 
treating HIV positive women of reproductive age are multiple: reductions in adult-to-adult 
HIV transmission, lowering maternal and infant morbidity and mortality, and preventing 
mother-to-child transmission of HIV (9-12). 
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The Prevention of Mother to Child Transmission  
The South African Prevention of Mother to Child Transmission (PMTCT) program 
started in 2001 aims to avert HIV infections in women and children. The PMTCT program 
includes interventions to improve HIV testing, place HIV positive women on treatment, 
prevent HIV infections in children, and avoid future HIV positive births through modern 
contraceptive use. Over 95% of pregnant women test for HIV during antenatal care (ANC) 
(1), however, every year in South Africa, 300,000 HIV positive mothers give birth, and many 
of their infants are born HIV positive due to non-use of PMTCT interventions (13).  It is 
important that HIV positive women eligible for ART start treatment. An HIV positive 
woman on treatment is less likely to transmit HIV to her child if both the mother and infant 
are treated per South African protocols. Many HIV positive births in South Africa are the 
result of unwanted pregnancies that could have been avoided through modern contraceptive 
use (25% of recent first births were unwanted, according to the most recent Demographic and 
Health Survey-DHS) (14). Modern contraceptive use is defined as the use of highly effective 
hormonal or barrier methods, and includes the following in South Africa: injectables, pills, 
intra-uterine device (IUD), sterilization, male or female condoms, diaphragm. Dual 
protection is the use of a hormonal method and a barrier method at the same time.  
As a component of South Africa’s PMTCT program, avoiding unwanted pregnancies 
in HIV positive women through modern contraceptive use is an excellent intervention 
because of its benefits for maternal and child health. Current modern contraceptive use averts 
120,256 HIV positive births in South Africa yearly according to estimates, and has the 
potential to avert even more (10). A recent study estimated the unmet need for contraception 
in South Africa at 15%, and that were this need met, over U.S. 3.3 million dollars would be 
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saved annually (15). Second, reductions in unwanted births may contribute to lowering the 
number of maternal and infant deaths, particularly for HIV positive women and children 
(12). The leading cause of excess maternal and infant death in South Africa is HIV/AIDS, 
and the maternal mortality rate for HIV positive women (340 deaths per 100,000 live births) 
is ten times higher than for HIV negative women (13). Third, reducing morbidity and 
mortality due to HIV/AIDS in women and children through modern contraceptive use is a 
cost-effective intervention (10, 12). For example, small decreases in unwanted pregnancies in 
HIV positive women are equivalent to approximately the same number of infant infections 
averted through anti-retroviral drugs (ART), yet modern contraceptives are much less 
expensive than ART drugs, and are therefore more cost effective (11). 
The History of Modern Contraceptive Use in South Africa 
Modern contraceptives were first available in the 1950’s and 1960’s in South Africa 
during Apartheid, a government system of racial segregation and repression that lasted from 
1948-1994 (16). Under Apartheid, South Africans were racially classified as white, 
Indian/Asian, colored (mixed race), or black African. Because health and family planning 
services were delivered based on race, with preferential treatment given to white South 
Africans, early adopters of modern contraceptive methods were wealthy and well educated 
white and Indian women (4, 16). In this system, black Africans had poor access to health 
services and essentially no access to family planning, due to racial discrimination. Starting in 
the 1970’s, the Apartheid government changed their policy and started promoting family 
planning methods to black South Africans.  The Apartheid government feared the growing 
size of the black population, which at the time was the largest racial group in the country, and 
therefore wanted to reduce the size of the black population by promoting contraception (4, 
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16, 17). To decrease population growth among black South Africans, injectable 
contraceptives were widely promoted to black women. By 1974, the National Family 
Planning program integrated family planning services into health services for all South 
Africans, including blacks.  
Historically, there is little information regarding family planning use during the 
Apartheid period because demographic information collected by the government was kept 
secret (17). According to one estimate, contraceptive prevalence in 1976 was between 37-
50% (18).  However, there are data from the late Apartheid period.  Conducted in 1987-1988, 
the South Africa Demographic and Health Survey (SADHS) is a probabilistic sample of 
women of reproductive age (12-49 years), and are the only data from the Apartheid period 
that include all racial groups and all geographic areas of South Africa. The original sample 
was 22,000 women in union or living with someone, or had given birth or were pregnant. 
Data presented below are from an analytic sample of 19,756 non-pregnant 15-49 year old 
women. Data were restricted to make them comparable to SADHS surveys conducted in 
1998 and 2003. 
Modern contraceptive use in 1987 differed by racial category and several other 
demographic factors. Black African women were least likely to use contraceptives (49%) 
compared to white (71%), colored (65%), or Indian/Asian women (66%) (16). For all racial 
groups, contraceptive use was higher in rural than in urban areas, except for black women. 
Fifty-eight percent of urban black women used contraceptives compared to 41% of rural 
black women (16). Modern contraceptive use for black African women by marital status was 
also different from other racial groups. Never-married black women were more likely to use 
contraception than ever-married black women (65% vs. 41%); yet the opposite was true for 
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other racial groups. Younger black, colored and Indian/Asian women (ages 15-24 and 25-34) 
were more likely to use contraceptives than women over 35, however, white contraceptive 
users were likely to be older. Modern contraceptive use increased with parity for colored, 
Indian/Asian and white women, but for black women, use increased after the birth of one 
child and then remained steady with additional children. 
 Over half (54%) of black women used an injectable, compared to 40% of colored 
women, 7% of Indian/Asian women and 4% of white women (16). The predominance of 
injectable contraceptive use among black South African women is thought to be the legacy of 
Apartheid family planning policies, where the injectable was promoted as the only family 
planning option (16, 19). This dominance of the injectable method among black South 
African women persists today.  
In summary, black South African women were less likely to use contraception in the 
late Apartheid period compared to all other racial groups, and black women who did use 
contraception were different demographically from other women. Black women who used 
modern contraception were likely to be younger, live in an urban area, not be married, to 
initiate use after the birth of one child, and to use an injectable method.  
Modern Contraceptive Use in Post-Apartheid South Africa  
 
Subsequent SADHS surveys in 1998 and 2003 suggest that modern contraceptive use 
continued to increase for South African women post-Apartheid. The greatest gains in 
contraceptive use were for black, rural South African women compared to all other racial 
groups. However, modern contraceptive use among black South African women still lagged 
behind women of other racial groups in 2003: 62% of sexually active black women used a 
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modern method compared to 70% for colored women, 75% for Indian/Asian women and 
80% for white women (14).  
In 2003, the Contraceptive Prevalence Rate (CPR) for sexually active women of all 
age groups was 65%, and was slightly higher for women not in union (68%), than for women 
in union (65%) (14). Between the 1998 and 2003 surveys, the proportion of sexually active 
women not in union increased. This likely contributed to the slightly higher CPR among 
women not in union compared to women in union, although the differences are small.  
Increases in current contraceptive use between the 1998 and 2003 surveys were evident in all 
age groups, except 20-24 year olds, where use remained stable. Current contraceptive use 
among sexually active women was dominated by the injectable (32%), followed by the pill 
(12%), female sterilization (10%), male or female condom (8%), IUD (0.5%), and male 
sterilization (0.5%) (14). Injectable contraceptive use declined in the younger age groups 
between 1998 and 2003 and was replaced with the use of male condoms.  Additionally, IUD 
use among sexually active women, which was already low, dropped even further (from 1.9% 
to 0.8%), as did female sterilization among women in union (from 16% to 14%) (14).  
Differences in contraceptive use between rural and urban populations narrowed over 
time. To achieve this between 1998 and 2003, current use of any modern method by sexually 
active women increased in rural areas (from 54% to 62%), and remained steady for urban 
areas (from 67% to 66%) (14). The same gains in narrowing the education gap in 
contraceptive use were not achieved. Contraceptive use was still highest in 2003 among the 
most educated South African women, and the higher the educational attainment, the higher 
the contraceptive prevalence. 
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In summary, between the late Apartheid period and 2003, contraceptive prevalence 
increased for all South African women of reproductive age, but most notably for rural black 
women. Differences in contraceptive use between rural and urban populations narrowed, 
contraceptive prevalence remained higher for more educated women compared to less 
educated women, and contraceptive use shifted from women in union to women not in union. 
Injectable methods of contraception remained most popular, and the use of male condoms 
increased for younger women.  
It is important to note that Apartheid affected partnership formation for black South 
Africans, which in turn affected contraceptive use by black South African women. South 
African family formation was disrupted when the imposed migrant labor system under 
Apartheid forced the separation of families (4). Men were forced to migrate to urban areas to 
work and women and children were relocated to rural Bantustans. Since the 1950’s, labor 
migration made traditional payments needed to marry (lobola) unaffordable and co-habitation 
without marriage became common (4). Today, 40% of black households are headed by 
females who typically live with their children and without a co-habiting or marital partner 
(14).  
The greatest increases in contraceptive prevalence between the 1998 and 2003 
SADHS surveys were evident in the province of KwaZulu-Natal (KZN). KZN had the 
highest contraceptive prevalence of modern method use among sexually active women (76%) 
of all nine South African provinces in 2003 (14). This was an increase of 19 percentage 
points from 1998. Despite high contraceptive prevalence in KZN, 23% of women used no 
contraceptive method at last sex and there remains an unmet need for family planning of 
6.8% (14). Although the unmet need for contraception in KZN is lower than South Africa 
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overall (6.8% versus 15%), the unmet need may differ by race, and is potentially higher for 
black South African women, given their lower levels of contraceptive use compared to other 
racial groups. Condom use and dual protection are low in KZN, even though overall modern 
contraceptive use is high (20). This has important implications for a province with the 
highest HIV prevalence in the world, as it leaves women vulnerable to HIV infection.  
HIV Status and Contraceptive Use 
Studies from sub-Saharan Africa demonstrate that the effect of learning one’s HIV 
status is a short-term increase in contraceptive use for HIV positive women compared to HIV 
negative women; however, this increase in modern contraceptive use is temporary, usually 
lasting a few months. A prospective cohort study of women in Lilongwe, Malawi assessed 
the effects of learning one’s HIV status on contraceptive use up to one year after diagnosis. 
Contraceptive use initially increased among HIV positive women, but decreased over time 
(21). Similar results were found in Kigali, Rwanda, where HIV positive women had initial 
higher contraceptive use compared to HIV negative women, but use in both groups declined 
after one and two years, primarily due to contraceptive discontinuation (22). Another study 
of HIV sero-discordant couples in Lusaka, Zambia showed initial increases in contraceptive 
use, but no impact on pregnancy incidence, and high levels of user failure and 
discontinuation (23). Several other studies in Uganda and Rwanda also found higher 
contraceptive use in HIV positive compared to HIV negative women of reproductive age, 
however, the study methods were cross sectional and bi-variate (Uganda) and the model mis-
specified (Rwanda) (24, 25). A study in Mwanza, Tanzania of PMTCT clients showed higher 
odds of ever family planning use and family planning use since giving birth for HIV positive 
women compared to HIV negative women, however, it wasn’t clear whether women knew 
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their HIV status, therefore the findings do not assess the effect of knowledge of HIV status 
on family planning use (26). Finally, in a multi-country population based analysis of DHS 
data from Zambia, Swaziland, Zimbabwe and Lesotho, Johnson et. al. found that women 
aware of their HIV positive status were more likely than HIV negative women or HIV 
positive women not aware of their status to use contraception (27).  
The findings from these studies all show a temporary effect of knowledge of HIV 
status on modern contraceptive use, but after one or two years, modern contraceptive use 
declines, and HIV status appears to have little effect on sustained contraceptive use. Instead, 
user failure and contraceptive discontinuation, or other changing factors such as fertility 
desire and socioeconomic circumstances, appear to become more important than HIV status 
alone, in the decision to use modern contraceptives. The Johnson multi-country study also 
highlights the importance of actually knowing one’s HIV status in order to understand the 
relationship between HIV status and contraceptive use. Prior studies, such as the one in 
Tanzania, are limited because women aren’t aware of their HIV status; therefore associations 
drawn between the effects of positive or negative HIV status and contraceptive use are not 
meaningful.  In South Africa, a majority of women do not know their HIV status, and 
therefore are unaware that they might infect not only their partner, but also future children if 
they were to become pregnant. The implications of these findings are that immediately 
following HIV diagnosis, HIV positive women are motivated to use contraceptives. 
Therefore, PMTCT programs should capitalize on their motivation during this period to 
educate women about how to overcome issues of user failure and discontinuation.  
In South Africa, knowledge of HIV status on contraceptive use is not fully 
understood. South Africa is completely different from other sub-Saharan African countries in 
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terms of contraceptive prevalence and fertility desires because contraceptive use is much 
higher and fertility desires much lower. In fact, South Africa’s fertility patterns and 
contraceptive use patterns more closely resemble a developed country. Therefore, the 
relationship between modern contraceptive use and HIV may be entirely different from other 
sub-Saharan African countries.  
Two studies in South Africa examine knowledge of HIV status and contraceptive use, 
but each has limitations, for different reasons. The first study in a PMTCT population in 
KwaZulu-Natal examined the odds of condom use one and two years post-partum for HIV 
negative and HIV positive Zulu women (28). The authors found that the odds of condom use 
were higher for HIV positive compared to HIV negative women. This study shows a short-
term increase in the odds of condom use for HIV positive women compared to HIV negative 
women, like in other countries, however, in this population, the effect persisted up to two 
years, unlike other countries. A limitation of the study was that the authors only reported the 
odds of condom use, not any modern method use or dual protection. The second study 
examined any modern contraceptive use in the post-partum period in a PMTCT population in 
Eastern Cape, and the authors found no differences in contraceptive use between HIV 
negative and positive women (29). This study does not support a short-term effect of HIV 
status on modern contraceptive use; however, the methods were weak because they did not 
control for demographic variation among the women. Additional research in South Africa 
will help to determine whether knowledge of HIV status affects contraceptive use, and if so, 
whether the effect is short or long term. These findings will help PMTCT program managers 
to improve contraceptive initiation and sustained use among women who want to space or 
limit childbearing. The key to sustaining contraceptive use among PMTCT attendees may be 
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intervening during the shorter-term period, or the post-partum period, when women are in 
contact with the healthcare system and motivated to use contraception after learning their 
HIV status.  
Contraceptive Use in the Post-partum Period 
Prior research indicates that women are amenable to contraceptive adoption in the 
post-partum period and that it may be an ideal time to counsel women about modern 
contraceptive use (30). A recent study of contraceptive adoption by HIV positive women in 
Russia showed that post-partum women were more likely to choose a highly effective 
contraceptive method compared to non post-partum women (31). This study suggests that not 
only is the post-partum period an ideal time to counsel women about modern contraceptive 
method use, but it also provides evidence that the post-partum period may be an great time 
for HIV positive women to consider contraception. In South Africa, I am aware of only one 
study that examines the post-partum adoption of contraceptive methods by HIV status (the 
PMTCT study of Zulu women in KZN described above) (28). In KZN, median post-partum 
amenorrhea is 2.4 months (~8 weeks) and median post-partum abstinence is 2.3 months (~8 
weeks)(14).  However, younger women report shorter periods of post-partum amenorrhea, 
and post-partum amenorrhea due to breastfeeding is only 0.7 months in urban areas (14).  A 
different study in Cape Town, South Africa examined whether advice about contraceptive 
use given antenatally increased contraceptive uptake one year later found no increased uptake 
(32). Additional research is needed in South Africa examining patterns of post-partum 
contraceptive use by HIV status. 
Studies from elsewhere in Africa show that post-partum initiation of contraception 
and intent to use contraception are associated with higher contraceptive continuation. Using 
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DHS data from Zimbabwe, Samibisa and Curtis found that contraceptive continuation rates 
were higher among women who initiated use early in the post-partum period compared to 
women who initiated use later (33). Another study from Morocco using DHS data 
demonstrated that there is a strong relationship between intent to use contraceptives and 
subsequent use, and that women who intended to use contraceptives but didn’t were more 
likely to have an unmet need for contraception (34). In a different study in Morocco, modern 
method adoption after birth was associated with the presence of a nearby public health center 
and lower method failure rates (35).  
Fertility  
Trends 
Fertility rates in South Africa slowly declined as women of reproductive age adopted 
modern contraceptives from the late Apartheid period to the present. These declines in 
fertility reflect South African women’s childbearing desires, which are unique in the sub-
Saharan Africa region because they are lower than other countries. Most South African 
women want two children on average, whereas in other sub-Saharan African countries, 
women want three or four children on average (14). Fertility rates declined in South Africa in 
the last 40 years, primarily due to increased contraceptive use since the 1970’s, which 
lengthened birth intervals (36-40). The total fertility rate in South Africa fell from 5.0 to 2.1 
children per woman of reproductive age from 1970 to 2003 (14, 41, 42). In the province of 
KwaZulu-Natal, fertility declined from 3.7 in 1996 to 2.8 in 2005 (39).  
Despite overall declines in fertility, there is evidence of a stall in the rate of fertility 
decline in South Africa, and it isn’t yet clear why the rate of decline slowed (39). In 
KwaZulu-Natal, the rate of fertility decline of 3.3% per year in the 1990’s slowed to 1.1% 
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per year from 2000-2005 (39). Evidence from other African countries experiencing a similar 
stall suggested a leveling in the demand for contraception and an increase in the wanted 
fertility rate as possible explanations for the slow in fertility decline (43-45). Moultrie et. al. 
argue that these are unlikely explanations for South Africa’s stall because women continued 
to adopt highly effective methods of contraception and fertility patterns did not conform to 
conventional conceptualizations of the fertility transition (39).  
In South Africa, over one third of young women experience an extramarital first birth 
before the age of 20; and 43% percent of first births are mistimed according to the most 
recent DHS (4, 14, 46). First births are generally wanted, however, they are not wanted at the 
time of the pregnancy for many South African women younger than age 20.   The mistiming 
of these births can be partially explained by several factors. First, there is intense social 
pressure, particularly for black South African women, to prove their fertility with a first birth 
in order to enhance their marriage prospects (47).  Because of this, pre-marital and adolescent 
childbearing are common for black South African women, particularly in KwaZulu-Natal (4). 
Second, adolescents generally do not access health services for contraceptives until after they 
experience a first birth, although the most recent DHS shows younger women are 
increasingly using contraceptives before a first birth, particularly condoms (14, 48).  
According to the 2003 DHS, 60% of women, whether in union or not, wanted no 
more children (14). The desire to cease childbearing varied by age, education and province. 
Thirty five percent of all 20-25 year olds wanted no more children and the desire to end 
childbearing increased with age (14). As a woman’s education level increased, so did her 
desire to end childbearing. Although KwaZulu-Natal had a lower proportion of women 
wanting no more children in 2003 compared to other provinces, two-thirds of women wanted 
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to cease childbearing when reaching a parity of two (14). In KwaZulu-Natal, modern 
contraception appears to be used for spacing between first and second births and limiting 
following second births.  
Unwanted Fertility 
Unwanted fertility is measured in the DHS by a series of questions about pregnancy 
intention. First, a woman is asked if her pregnancy was intended. If the pregnancy was 
unintended, then a woman is asked whether the pregnancy was wanted later (mistimed) or 
not wanted at all (unwanted) (14).  Levels of unwanted fertility using this method are 
surprisingly high in South Africa given the elevated levels of highly effective contraceptive 
use and the overall declining fertility rate. Using this method of measurement, twenty five 
percent of recent first births were unwanted and 23% of all births to South African women in 
the 5 years preceding the DHS survey were unwanted (14). Unwanted fertility also varied by 
age. Thirty four percent of unwanted births were to women under the age of 20. Among 
women of other age groups, unwanted births varied between 15-34% (14) . Eliminating 
unwanted fertility, using DHS figures, would reduce the total fertility rate from 2.1 to 1.6, a 
rate similar to countries with low fertility and below replacement fertility level (14). 
A different way to measure unwanted fertility, also used by the DHS, but developed 
by Lightbourne, is to calculate whether actual family size exceeds a stated ideal family size at 
the time of conception (49-51). This measure of unwanted fertility suffers from two potential 
types of bias. First, when stating an ideal family size, it is not uncommon in developing 
countries for participants to give a non-numeric response, such as “It is God’s will” (49, 50). 
However, in the case of the data used to measure this concept for this study, there are no non-
numeric responses, so this should not bias the findings. Another limitation is 
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“rationalization,” which is stating an ideal number of children close to the actual number of 
children. This happens because women are reluctant to report having “unwanted” children, 
and will bias estimates of unwanted fertility down (49, 50). 
Unwanted fertility is an important measure to understand in PMTCT populations in 
South Africa because one of the objectives of PMTCT family planning programs is to reduce 
unwanted fertility, particularly among HIV positive women. Using the second measure of 
unwanted fertility in a population of rural women of childbearing age from India, the authors 
of one study found that the desire to stop childbearing was significantly higher for women 
who had experienced unwanted fertility compared to women who had not (50). Because 
these women were more motivated to end childbearing, they were likely more in need of 
contraception, and with the right counseling, more likely to adopt contraception. The authors 
conclude that women experiencing unwanted fertility may require more counseling and 
monitoring to ensure contraceptive use to avoid additional unwanted fertility. Given the high 
rates of unwanted fertility in South Africa, understanding unwanted fertility in PMTCT 
populations will aid health workers in identifying women who may need additional 
contraceptive counseling to avoid additional unwanted fertility, especially for HIV positive 
women.  
HIV/AIDS and Fertility Desires 
 There is a growing body of evidence about whether HIV/AIDS status affects 
women’s fertility desires, and the evidence is mixed. Studies from sub-Saharan African 
countries fall into three broad categories: 1. An HIV positive diagnosis is associated with 
lower fertility desire, 2. HIV status has no bearing on future fertility decisions, and 3. An 
HIV positive diagnosis increases women’s fertility desire. 
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 Several studies showed that women who know they are HIV positive do not want 
more children. Using DHS data from Zambia, Swaziland, Zimbabwe and Lesotho Johnson et. 
al. found that women with an HIV positive test result received in the prior year were less 
likely to want a/another child compared to HIV negative women or women who hadn’t 
received their test result, and the desire to limit births was higher for recently tested HIV 
positive women compared to recently tested HIV negative women (27). Upon receiving an 
HIV diagnosis, HIV positive women in Rwanda and Zimbabwe were more likely to report 
that they did not want any more children compared to HIV negative women (22, 52, 53). 
Measures of fertility intent asked immediately after HIV diagnosis are likely to suffer from 
social desirability bias. Women may be more likely to report that they no longer want 
children if they are HIV positive because societal attitudes and healthcare provider’s attitudes 
about HIV positive women bearing children are often negative (54-57).  
Despite negative societal attitudes, a number of studies found that positive HIV status 
actually increases women’s fertility desire, particularly for women on anti-retroviral 
treatment (ART) or for women who do not have children. Evidence from South Africa, 
Kenya and Uganda showed that HIV positive women on ART are more likely to want more 
children than women not on treatment (8, 58, 59).  Women on ART treatment are likely to be 
healthier, more hopeful about the future and more likely to be sexually active than women 
not on treatment; therefore they are optimistic about a pregnancy. HIV positive women who 
have no children are still likely to want at least one child because of social expectations that 
women should bear children (8, 60). In South Africa, HIV positive women from a study 
conducted in Cape Town still wanted children because children were a sign of hope and 
normality (8).  
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Several studies in sub-Saharan Africa show that HIV status has no effect on fertility 
desire. Research from Zambia, Zimbabwe, Cote d’Ivoire, Kenya, Rwanda, South Africa and 
Tanzania showed HIV status did not have a depressing effect on fertility desire because 
social, cultural and health factors outweighed HIV status on decisions about childbearing 
(61-63). Fertility desire may remain unchanged in societies where childbearing is highly 
valued and confers social status (8, 60).  
A majority of studies to date in sub-Saharan Africa examine fertility intentions and 
whether they change after learning one’s HIV status, however, they do not examine actual 
fertility experiences and how they might interact with HIV status to affect contraceptive use. 
This study examines a measure of actual fertility experience (unwanted fertility) and its 
interaction with HIV status and how this affects post-partum contraceptive use. The findings 
from this study will inform PMTCT program managers about whether targeting post-partum 
contraceptive counseling to women who have experienced unwanted fertility, and are HIV 
positive, is important.  
Health Facility Factors Influencing Contraceptive Use 
 The HIV/AIDS and family planning literature predominately examines individual 
level factors influencing fertility preferences, pregnancy planning and contraceptive use, yet 
contextual factors such as community beliefs, presence and quality of health services, 
transportation routes and other economic factors may influence contraceptive use (64). In 
sub-Saharan Africa, recent studies suggest several health systems factors that may influence 
women’s contraceptive adoption and merit additional investigation. These factors include: 
the contraceptive method mix offered at government health facilities, contraceptive 
counselor’s level of knowledge about contraceptive methods, waiting times at public health 
 20 
facilities and service integration (Voluntary Counseling and Testing-VCT, Family Planning-
FP, Maternal and Child Health-MCH).  
 Contraceptive use in South Africa is dominated by injectable methods (Depo-Provera 
and Nuristerate), which account for approximately one third of all contraceptive method use, 
and 83% of women receive contraceptives from the public sector, where they are free (14). 
Therefore, there is a clear preference for injectable contraceptive use in government facilities 
in South Africa. The advantages of injectable methods are that women only need an injection 
every 2-3 months and therefore they only need to visit a health facility a few times a year, the 
method is not visible so women can utilize it even if their partner is opposed, and injectables 
are cost effective (65). The disadvantages are that injectables do not protect against sexually 
transmitted diseases, they are painful for some women, and women using injectable methods 
often experience side effects such as bleeding, headache or weight gain (66). Discontinuation 
rates are higher for injectable methods compared to other methods such as the pill and IUD 
(66). In South Africa, the method mix may play an important role in contraceptive 
continuation. If women on injectables experience side effects, they may discontinue the 
method and not be aware of other methods or have access to them. Studies from elsewhere 
show that when women are given a choice of contraceptive methods, continuation rates are 
higher (67, 68). Given high rates of unwanted pregnancy despite high levels of contraceptive 
use in South Africa, discontinuation may be of concern, and changing the method mix may 
be important for overcoming issues of discontinuation.  
In public health facilities in sub-Saharan Africa, efforts to integrate HIV and family 
planning services show limited success in increasing contraceptive uptake, but elucidate 
several areas where government facilities can improve in order to more effectively promote 
 21 
contraceptives to their clients (69-73). In an integration study of family planning into VCT 
services in government facilities in Ethiopia, the authors found that the counselor’s 
perception of available contraceptive methods (perception of the method mix and stock), 
influenced client’s contraceptive uptake and intent to use condoms (69). Additionally, the 
counselor’s level of knowledge about contraceptive side effects was also associated with 
whether the client adopted a contraceptive method or not (69). Long waiting times at 
government facilities deter clients and have been shown to be associated with client 
dissatisfaction (74, 75). In South Africa, high patient volume and limited resources result in 
long waiting times, potentially deterring clients seeking HIV and family planning services 
(76). Two studies from Eastern Cape, South Africa examined government health facility 
factors influencing individual contraceptive use and choice (42, 77). The first study included 
the following health facility factors: distance to the facility, staffing levels, staff training in 
family planning, availability of family planning services and presence of family planning 
methods (42). Only distance to the health facility was significant in the model and women 
who lived farther from the facility were more likely to use contraception than women who 
lived closer to the facility (42). The second study examined the following health facility 
factors and their associations with contraceptive method choice: number of doctors, number 
of community health workers, number of nurses trained in HIV/AIDS, number of expired 
contraceptive methods in stock and health facility asset score (77). The authors found that the 
presence of more doctors was associated with increased use of the pill and permanent 
contraceptive methods, and women living in communities where health facilities had more 
assets (e.g. contraceptive methods in stock, number of staff) were more likely to use an IUD 
or be sterilized rather than an injectable method (77). 
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Several other studies in South Africa show a need for further research about health 
systems factors influencing contraceptive use among government facility clients. A study of 
two types of integration: 1. VCT at family planning services, and 2. Referral to VCT from 
family planning services, showed increased HIV testing in both models compared to standard 
practice, that providers and clients discussed family planning more in the referral model 
compared to the other models, but contraceptive use in the two models did not increase 
compared to the standard (78). Another study examining the integration of HIV/FP/MCH 
services in rural and urban settings in KZN showed that 14% of MCH clients needed family 
planning advice but were not receiving it and 30% of family planning and MCH clients were 
at high to medium high risk for HIV infection, but received no information about HIV (79). 
A qualitative study of family planning and maternal and child health clients at government 
facilities in Cato Manor, just outside of Durban, demonstrated that women are rarely 
counseled on a range of family planning methods, they have little opportunity to ask 
questions about family planning, and they do not understand the purpose of antenatal care 
(80). For a majority of South African women, antenatal care is their first point of contact with 
the healthcare system, and is therefore an ideal place to counsel women about modern 
contraception (79). Further research is needed in South Africa to identify government facility 
factors influencing contraceptive adoption among PMTCT clients in order to develop more 
effective interventions.  
 
 
 
  
 
Chapter 3: Analytic Framework and Mixed Methods Approach 
 
Analytic Framework 
 
The analytic framework (Figure 1) guides the theoretical and analytical approach. The 
constructs in the framework are based on individual level social cognitive theories of 
behavior and frameworks for HIV/AIDS research. The framework draws from the 
component of the Theory of Reasoned Action (TRA) that focuses on behavioral intent and 
performance (81). Fishbein and Ajzen’s Theory of Reasoned Action posits that individual 
intentions directly influence future behaviors (82, 83). Behavioral intent has been shown to 
be a medium to strong predictor of behavioral performance, including modern contraceptive 
use, and is measured using self-report (84-90). Specifically, the relationship between intent to 
use contraceptives (Measured at Time 1 or Baseline) is examined in relation to actual 
contraceptive use (future behavioral performance; Measured at Time 3 (14 weeks post-
partum) at the individual level.  There is evidence that past behavioral performance (in this 
study, ever contraceptive use) directly influences intent (84), therefore ever contraceptive use 
is an important control variable in the conceptual model. Another important control variable 
identified in South Africa is the influence of female family members (or “referents” in the 
Theory of Planned Behavior (TPB), which expands upon the TRA), on contraceptive use (86, 
91).  The presence of other female household members is included as a control variable in the 
model. HIV status is examined as a potential moderating factor between the intent to use 
contraceptives and actual use, as well as a direct influence on contraceptive use (92).  Both 
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relationships are explored because prior research has not yet elucidated whether HIV status is 
a direct or moderating influence on contraceptive use (21-23, 93).  
 Protection Motivation Theory (PMT) is used to examine HIV status and unwanted 
fertility in the analytical model. PMT posits that threatening health information (in this study, 
knowledge of HIV positive status and experience of unwanted fertility) affects attitudes 
toward a health behavior as well as behavior change (94). According to PMT, information 
about a health threat initiates a cognitive mediating process, during which individuals 
undergo parallel processes of threat appraisal and coping appraisal, which result in either a 
maladaptive response (e.g. non-contraceptive use) or an adaptive response (e.g. 
contraceptive use) (94, 95).  PMT is often used to measure a behavioral intent outcome, 
however, several studies also use PMT to measure actual behavior as an outcome (95, 96). 
The level of protection motivation in this study is measured using actual behavior as an 
outcome (contraceptive use). Using PMT, I hypothesize that the threat of HIV positive status 
will prompt women to adopt an adaptive response (e.g. increase the probability of 
contraceptive use post-partum) compared to HIV negative women. I also hypothesize that 
women who experienced unwanted fertility will adopt an adaptive response compared to 
women who did not experience unwanted fertility, and that the threat of HIV positive status 
and unwanted fertility will make women even more likely to adopt an adaptive response and 
will have an even higher probability of contraceptive use. 
Previous concepts described in the analytic framework are measured at the individual 
level; however, several HIV/AIDS researchers assert that conceptual models and frameworks 
must also include other underlying, proximal and distal determinants of health behaviors, 
particularly in sub-Saharan Africa (85, 97). One HIV/AIDS framework supports the 
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inclusion of three levels: 1. Personal attributes (cognition and feelings about sexual behavior 
and HIV/AIDS; thoughts about self), 2. Proximal context (interpersonal relationships; 
physical and organizational environment) and 3. Distal context (culture, e.g. societal norms, 
social discourse, shared beliefs and values; structural factors e.g. legal, political, economic) 
(85). Another HIV/AIDS framework examines three levels of determinants of health and 
demographic outcomes: 1. Underlying determinants (context and intervention programs), 2. 
Proximate determinants (individual level behaviors), 3. Biological determinants (individual 
level biology) (97).  There is no one social cognitive behavioral model or HIV/AIDS 
framework that incorporates both individual level and underlying determinants of 
contraceptive use and HIV/AIDS infection, despite the fact that both are outcomes 
determined by sexual behavior. In this study, I examine individual level behaviors, but also 
acknowledge the importance of more distal and underlying factors influencing individual 
behaviors. Specifically, I explore health facility factors related to modern contraceptive use. 
These factors are included in the analytical framework as a potentially important construct 
influencing individual level modern contraceptive use.  
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Figure 1: Analytic Framework:  Unwanted Fertility Experience, HIV Status and Post-partum Contraceptive Use in a PMTCT 
Population in Durban, South Africa 
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Mixed Methods Approach 
This study uses a mixed methods approach, utilizing both qualitative and 
quantitative research techniques, to examine individual level factors (specifically HIV 
status and unwanted fertility) influencing post-partum contraceptive use and dual 
protection, as well as health facility level factors influencing the same outcomes. 
Individual level data are drawn from an HIV counseling and testing intervention study, 
the South Africa HIV Antenatal Post-test Support Study (SAHAPS), implemented at an 
antenatal clinic located in an urban township outside of Durban, South Africa. Facility 
level data were collected from clinic staff and clients.  
 A mixed methods approach is utilized for this study for several reasons. To 
determine the effect of learning one’s HIV status and unwanted fertility on post-partum 
contraceptive use (Specific Aims 1 and 2), data are needed from a sample of HIV positive 
and negative women who have just given birth. Quantitative data from women attending 
an antenatal clinic are most appropriate to determine the effect of HIV positive status 
relative to HIV negative status on contraceptive use. Contraceptive use is measured using 
quantitative assessments that allow for control of potential confounding factors that might 
obfuscate the relationship between HIV status and/or unwanted fertility and contraceptive 
use. Many individual level factors associated with contraceptive use (e.g. education level, 
parity, marital status, age) have already been identified in the literature (including studies 
from South Africa) and can be utilized in quantitative models to strengthen findings 
about the relationships of interest in this study. 
 Qualitative methods are used for Specific Aim 3 in order to describe the health 
facility context that influences individual level behaviors measured in Specific Aims 1 
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and 2. Several studies from sub-Saharan Africa suggest that facility level factors, such as 
the client-provider interaction, the contraceptive method mix available, contraceptive 
counselor’s level of knowledge about contraceptive methods and client waiting times 
may also influence individual level contraceptive use. Several health facility factors in 
South Africa have been identified as important influences on individual contraceptive 
use. These health facility factors include: waiting times, distance to the health facility for 
the client, the number of doctors at the health facility, the number of health facility assets 
(e.g. contraceptive methods in stock, counselors available), counselor’s knowledge and 
explanation of a range of contraceptive methods and counselor’s allowing clients the 
opportunity to ask questions about contraceptives (42, 64, 76, 80). Quantitative data 
about these specific health facility factors were not collected as part of SAHAPS study; 
therefore, these factors cannot be included in quantitative models. In this study, I focus 
specifically on the client-provider interaction when contraceptive methods are discussed 
and recommended. Qualitative methods are used to understand and explore this 
relationship, as well as other health facility factors relevant to the clinic.  
Study Setting 
The study setting is an urban township outside the city of Durban in the province 
of KwaZulu-Natal (KZN). KZN is an ideal place to study the effects of HIV status and 
unwanted fertility on post-partum contraceptive use. The HIV prevalence in KZN is 
16.5%, and as high as 40% among pregnant women testing in antenatal care (6, 98). 
Contraceptive use among sexually active women in KwaZulu-Natal is high at 76%, 
however, 23% of women used no method at all at last sex (14).  Some of these women 
may desire pregnancy, but for others, non-use of a contraceptive method at last sex leaves 
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them vulnerable to both HIV infection and unintended pregnancy.  Fifty-four percent of 
currently married women in KZN want no more children, and this percentage increases 
with parity (14). Reaching these women in antenatal care with contraceptive options 
potentially can reduce the unmet need for family planning, which in KZN is 6.8%, and 
assist women to better plan the timing, spacing and limiting of their pregnancies (14). 
Further, post-partum contraceptive adoption also contributes to meeting South Africa’s 
PMTCT program goals.  
Study Site 
The study site is a government public health clinic in an urban township. The 
clinic is staffed by one physician and 15 nurses and offers services 24 hours a day, seven 
days a week. The township was established during Apartheid as a settlement where black 
migrant laborers resided after working in the city during the day. It is the biggest 
township in KwaZulu-Natal (99) and the second biggest in the country (100). The 
population estimate for the township varies considerably depending on whether the 
enumerators included informal settlers or not in their estimation; the lower bounded 
estimate suggests that 300,000 people reside there (101) while the upper bounded 
estimate suggests the population is nearly 2,000,000 (100).  The community has one 
hospital that serves the 17 clinics in the surrounding area.   
Ethical Approval 
 All study methods and procedures were approved by the Biomedical Research 
Ethics Committee at the University of KwaZulu-Natal located in Durban, South Africa 
and the University of North Carolina at Chapel Hill, Chapel Hill, USA, as well as the 
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Regional South African Department of Health office and the head supervisor at the 
research site.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter 4: Quantitative Methods and Results 
 
Methods 
 
The South Africa HIV Antenatal Post-test Support Study 
Data are from the South Africa HIV Antenatal Post-test Support Study 
(SAHAPS), a randomized controlled trial examining the efficacy of an integrated model 
of HIV post-test support for women attending antenatal care in Durban, South Africa. 
One thousand five hundred pregnant women attending antenatal care at a government 
clinic in an urban township were enrolled in the study between 2007-2010. At baseline, 
all women completed a questionnaire including: demographics, HIV testing and 
disclosure, social support, sexual risk behaviors, power and violence, PMTCT, infant 
feeding, family planning, legal needs and emotional distress. Women were randomized at 
baseline to standard World Health Organization (WHO)/Centers for Disease Control and 
Prevention (CDC) HIV counseling and testing or an enhanced counseling and testing 
intervention. Women randomized to the intervention arm also received: 1. A health 
education video before HIV counseling and testing, 2. Enhanced counseling before and 
after HIV testing, including additional discussions of risk reduction, disclosure and 
PMTCT decisions, 3. Counseling about legal education at 6 weeks post-partum, 4. 
Counseling about family planning at 10 weeks post-partum.  Following the baseline 
questionnaire and randomization, women were counseled and tested for HIV. Women 
were then followed longitudinally at 6 weeks post-partum, 10 weeks post-partum, 14 
weeks post-partum and 9 months post-partum.  Data are from questionnaires 
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administered at baseline and 14 weeks post-partum. I did not use data from the 6 and 10 
week visits because very few women did a 6 or 10 week visit and few women had 
resumed sexual activity by then, therefore there was little data on important variables.  
Eligibility 
Women eligible to participate in the SAHAPS study were age 18 or older, were 
pregnant at enrollment, had an intimate partner for six or more months, planned to reside 
in Durban for a year following enrollment, and gave informed consent. Women were 
eligible to participate if they had never tested for HIV before or if they had tested HIV 
negative previously. Women were not eligible if they had tested HIV positive previously. 
SAHAPS is a collaborative study between the University of KwaZulu-Natal (UKZN) 
located in Durban and the University of North Carolina at Chapel Hill (UNC-CH), and 
has been approved by institutional review boards at both institutions.  
Interview Procedures 
 Women were recruited from the ANC clinic at the study site. Women who met 
eligibility criteria and gave informed consent were interviewed in Zulu by a trained 
interviewer who captured the data on a computer. Women were reminded about follow-
up appointments with an appointment reminder card, and if missed, were then traced by a 
driver and tracer (a staff member who followed-up with participants about missed 
appointments). HIV testing was conducted by a study nurse at the first antenatal visit and 
a separate consent process was used for HIV testing. Women were interviewed again in 
Zulu by a trained interviewer who captured the data on a computer at 14 weeks. 
Interviews lasted one to one and a half hours and participants were remunerated with 50 
Rand (~U.S. $6) at each visit for transportation.   
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Analytic Sample 
 One thousand fifteen hundred women completed the baseline questionnaire, 
however, 20 women refused to test for HIV during the study and were excluded (See 
Figure 2). Of the 1,480 women who completed a questionnaire at baseline and tested for 
HIV, 1,154 (78%) also completed a 14-week visit. Two hundred seventy six women were 
not sexually active (N=275) or pregnant (N=1) at 14 weeks and were excluded. Further, 
32 women were missing data on modern contraceptive use at 14 weeks and were 
excluded. Therefore the final analytic sample of 846 included women who completed a 
baseline questionnaire, tested for HIV, were sexually active at 14 weeks and had data on 
modern contraceptive use at 14 weeks. The sample sizes for each of the final models 
varied due to missing values on baseline, independent and dependent variables (see 
Figure 2).  
Of the 326 women lost to follow-up, they were demographically similar on 
variables included in the analyses, except for HIV status. Women lost to follow-up were 
more likely to be HIV positive (N=142/326 or 43% compared to 38% N=565/1480).  
Analysis 
 I used several logistic regression models with robust standard errors to examine 
the relationships of interest (see Table 3 for results). I used the same control variables for 
all models (see Table 2). Analyses were conducted using Stata 11 (102).  
Model 1 
I examined whether intent to use contraceptives at baseline and knowledge of 
HIV status affect women’s modern contraceptive use post-partum. The first hypothesis 
was: women who intend to use modern contraceptives post-partum and test HIV positive 
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are more likely to use contraceptives post-partum than women who intend to use 
contraception post-partum and test HIV negative.  
The independent variable of interest in Model 1 is a woman’s intent to use 
modern contraception.  The variable was measured at baseline using a computer-assisted 
questionnaire. Women were asked:  Would you like to have more children immediately 
after this pregnancy? Sixty six percent of women did not want more children. Women 
were then asked: If you would not like to have children after the child you are expecting, 
are you planning to use something to protect yourself after this pregnancy? The intent 
variable was dichotomized as yes for women who plan to use something to protect 
themselves and no for women who do not intend to use something to protect themselves 
or do not know. I included women who wanted another child (N=117) in the No/Don’t 
know category. Seventy four percent of HIV positive women and 70.5% of HIV negative 
women at baseline intended to use contraceptives (see Table 1).  
 The main dependent variable is modern contraceptive use post-partum at 14 
weeks.  Data were derived from the following question:  Are you currently using any of 
the contraceptive methods to prevent future pregnancy? Women currently using a 
modern method were coded as yes and those not using a modern method no. Modern 
method use was defined as: pill, injectable, intra-uterine device (IUD), male condom, 
female condom, sterilization, and dual protection (use of a hormonal method and a 
condom). At 14 weeks, 86% of HIV positive and 84% of HIV negative women reported 
modern contraceptive (see Table 1). I included the control variables listed in Table 2 in 
the model.  
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 HIV status is hypothesized to be a moderating variable in this model.  HIV status 
data were recorded in a baseline medical file. HIV status was dichotomous and coded as 
HIV positive or HIV negative.  
Model 2 
I examined whether knowledge of HIV status affects women’s modern 
contraceptive use post-partum. The second hypothesis was: women who test HIV positive 
are more likely to self-report condom use and dual protection (use of a condom and a 
hormonal method) post-partum compared to women who test HIV negative.  
The dependent variables for Model 2 are measures of condom use and dual 
protection. The first dependent variable is a measure of condom use at 14 weeks. Data 
were derived from the following question:  Are you currently using any of the following 
contraceptive methods to prevent future pregnancy? Women currently using condoms 
were coded as yes and those not using condoms were coded no. A second dichotomous 
dependent variable, dual protection, was created utilizing data from the same question 
mentioned above, except that women who used both a condom and another hormonal 
contraceptive method were coded as yes and those utilizing no method or only one 
modern method were coded no.  At 14 weeks post-partum, 14% of HIV positive women 
and 28% of HIV negative women reported condom use (see Table 1).  Twenty two 
percent of HIV positive women and 12% of HIV negative women reported dual 
protection (see Table 1).  I included the control variables listed in Table 2 in the model.  
The main independent variable of interest in Model 2 is HIV status. HIV status 
was recorded at baseline in a medical file.  The variable is dichotomous: HIV positive or 
HIV negative status.  
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Model 3 
I examined whether unwanted fertility experience affects post-partum modern 
contraceptive intent. The third hypothesis was: women who have experienced unwanted 
fertility are more likely to report intent to use contraceptives in the future than women 
who have not experienced unwanted fertility. 
The independent variable of interest in Model 3 is whether or not a woman has 
experienced unwanted fertility. This variable is a dichotomous variable (yes or no) 
measured at baseline. Unwanted fertility is defined as having more children than a stated 
ideal number at baseline. This variable was calculated by subtracting a woman’s actual 
number of children at baseline (including her current pregnancy) from a woman’s ideal 
number of children at baseline. If the result is less 0, then she has experienced unwanted 
fertility.  If the result is greater than or equal to 0, then she has not experienced unwanted 
fertility. Eight percent of HIV positive women experienced unwanted fertility and 5% of 
HIV negative women experienced unwanted fertility (see Table 1).  
The main dependent variable is intent to use modern contraceptives in the next 12 
months, measured at 14 weeks. The data are from the following question: Do you intend 
to use a method to delay or avoid pregnancy within the next 12 months? The variable is 
dichotomous with responses of yes or no. Ninety percent of HIV positive women and 
89% of HIV negative women reported that they intended to use contraception in the next 
12 months (see Table 1). HIV status is hypothesized to be a moderating variable in this 
model.  HIV status data were recorded in a baseline medical file. I included the control 
variables listed in Table 2 in the model.  
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Model 4 
I examined whether unwanted fertility and HIV status affect post-partum modern 
contraceptive use. The fourth hypothesis was: women who have experienced unwanted 
fertility and test HIV positive are more likely to self-report current modern contraceptive 
use than women who have experienced unwanted fertility and who test HIV negative.  
The independent variable of interest in Model 4 is whether or not a woman has 
experienced unwanted fertility. This variable is a dichotomous variable (yes or no) 
measured at baseline. Unwanted fertility is defined as described above. The main 
dependent variable is modern contraceptive use at 14 weeks post-partum. At 14 weeks, 
At 14 weeks, 86% of HIV positive and 84% of HIV negative women reported 
modern contraceptive (see Table 1). I included the control variables listed in Table 2 in 
the model. HIV status is hypothesized to be a moderating variable in this model.  HIV 
status data were recorded in a baseline medical file. HIV status is dichotomous and was 
coded as HIV positive or HIV negative.  
Results 
Demographics 
 Of the 846 women included in the analytic sample, 159 HIV positive women and 
279 HIV negative women were in the intervention arm and 141 HIV positive women and 
267 HIV negative women were in the control arm. Sixty four point five percent of 
participants in the analytic sample were HIV negative (N=546) and 35.5% (N=300) were 
HIV positive.  The average age for HIV positive women was 26 and 25 for HIV negative 
women. Most HIV positive women had completed grades 8 to 11 (49%) and most HIV 
negative women had completed high school (Matric-52%).  A majority of HIV positive 
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and negative women were Zulu speaking and Christian. HIV positive women were 
employed (46%) and HIV negative women were housewives (44%). See Table 2 for 
more demographic details.  
 Very few women were married and most were partnered but not living together. 
HIV positive and HIV negative women had been in a relationship for an average of 4 and 
5 years, respectively. A majority of women did not know if their partner had tested for 
HIV.  The average age at first sex reported by women was 18 years old (range: 9-34) and 
this did not differ by HIV status. Women reported an average of 2.5 lifetime sexual 
partners (range: 1-28) and the average was higher for HIV positive women (2.9 partners) 
compared to HIV negative women (2.3 partners). Sixty three percent of HIV positive and 
65% of HIV negative women had ever used a contraceptive method. Most HIV positive 
women had experienced two births and most HIV negative women had experienced one 
birth. See Table 2 for more details.  
Model 1 Results 
I used a logistic regression model to analyze the relationship between 
contraceptive intent at baseline and modern contraceptive use at 14 weeks, with HIV 
status as a moderating variable. Intention to use contraceptives at baseline is associated 
with a 13% reduction in the odds of contraceptive use at 14 weeks (OR: 0.87, 95% CI: 
0.51-1.50); however, this finding was not statistically significant (p=0.62) (see Table 3).  
The ratio of odds ratios for contraceptive use for women who intended to use modern 
contraceptives post-partum and tested HIV positive compared to women who intended to 
use contraception post-partum and tested HIV negative was 0.82 (95% CI: 0.31-2.16) 
(see Table 3). The confidence interval for the ratio of odds ratios includes the value of 1, 
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and this suggests that the interaction between intent to use contraceptives at baseline and 
HIV status was not significant in the model (103).  Therefore I cannot reject the null 
hypothesis:  there is no effect of intent to use contraceptives and HIV status on post-
partum contraceptive use.  
Model 2 Results 
I used two logistic regression models to examine the relationship between HIV 
status and condom use at 14 weeks post-partum, and HIV status and dual protection at 14 
weeks post-partum. In the first model where I examined the relationship between HIV 
status and condom use, the odds of condom use for HIV positive women were 2.26 times 
(95% CI: 1.61-3.18) the odds of condom use for HIV negative women and the finding 
was statistically significant at p=0.00 (see Table 3). The odds of condom use for women 
who had completed primary school or less or grades 8 to 11 were lower compared to 
women who completed Matric (the high school equivalent in South Africa), OR: 0.40 
(95% CI: 0.18-0.86) p=0.02; OR: 0.75 (95% CI: 0.53-1.06) p=0.10 respectively. The 
odds of condom use at 14 weeks for women who had ever used contraceptives were 1.88 
times the odds of contraceptive use for women who had never used contraceptives  (95% 
CI: 1.34-2.64, p=0.00). In the second model examining the relationship between HIV 
status and dual protection, the odds of dual protection for HIV positive women were 2.27 
times (95% CI: 1.44-3.56) the odds of dual protection for HIV negative women and the 
finding was statistically significant at p=0.00 (see Table 3). The odds of dual protection 
for women who had ever used contraceptives were 2.78 times (95% CI: 1.72-4.50 
p=0.00) the odds of dual protection for women who had never used contraceptives. The 
hypothesis that women who test HIV positive are more likely to self-report condom use 
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and dual protection (use of a condom and a hormonal method) post-partum compared to 
women who test HIV negative is supported by the findings in the two models.  
Model 3 Results 
I used a logistic regression model to analyze the relationship between unwanted 
fertility at baseline and intent to use modern contraceptives in the next 12 months, with 
HIV status as a moderating variable. Unwanted fertility experience at baseline is 
associated with a 35% reduction in the odds of intent to use contraception at 14 weeks 
(OR: 0.65, 95% CI: 0.18-2.27), but the finding was not statistically significant (p=0.50) 
(see Table 3).  The ratio of odds ratios for intent to use contraceptives for women who 
experienced unwanted fertility and tested HIV positive compared to women who 
experienced unwanted fertility and tested HIV negative was 2.82 (95% CI: 0.24-33.58) 
(see Table 3). The confidence interval for the ratio of odds ratios includes the value of 1, 
and this suggests that the interaction between unwanted fertility experience and HIV 
status was not significant in the model (103).  Therefore I cannot reject the null 
hypothesis:  there is no effect of unwanted fertility and HIV status on intent to use 
contraceptives in the future.  
Model 4 Results 
I used a logistic regression model to analyze the relationship between unwanted 
fertility at baseline and modern contraceptive use at 14 weeks post-partum, with HIV 
status as a moderating variable. Unwanted fertility experience at baseline is associated 
with an 67% reduction in the odds of contraceptive use at 14 weeks (OR: 0.33, 95% CI: 
0.11-1.00), and was statistically significant at p=0.05 (see Table 3).  The odds of modern 
contraceptive use at 14 weeks for women who had ever used contraceptives were 1.48 
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times (95% CI: 0.99-2.24) the odds of contraceptive use for women who had never used 
contraceptives (p=0.06). The odds of modern contraceptive use for women who had 
experienced three or more births were 2.12 times the odds of contraceptive use for 
women who had experienced two births (95% CI: 1.00-4.44; p=0.05). The ratio of odds 
ratios for contraceptive use for women who experienced unwanted fertility and tested 
HIV positive compared to women who experienced unwanted fertility and tested HIV 
negative was 2.07 (95% CI: 0.39-10.88). The confidence interval for the ratio of odds 
ratios includes the value of 1, and this suggests that the interaction between unwanted 
fertility experience and HIV status was not significant in the model (103).  Therefore I 
cannot reject the null hypothesis:  there is no effect of unwanted fertility and HIV status 
on contraceptive use post-partum.  
Discussion 
 
 In the multivariate analysis in Model 1, intent to use contraceptives at baseline did 
not predict post-partum contraceptive use.  Women who intended to use contraceptives at 
baseline were less likely to use them post-partum than women who did not intend to use 
them at baseline; however, the finding was not statistically significant. Further, HIV 
status in Model 1 did not have a moderating effect in predicting post-partum 
contraceptive use. Of the 1,060 women who intended at baseline to use contraception 
post-partum, 607 did a 14 week-visit, were sexually active and had data on post-partum 
contraceptive use. Eighty five percent of women who intended to use contraceptives at 
baseline and also did a 14-week visit (518/607) actually used contraceptives post-partum. 
Interestingly, 201 women who did not intend to use contraception at baseline reported 
post-partum contraceptive use. Therefore 85% of women who did not intend to use 
contraceptives post-partum ended up using contraceptives post-partum (201/238). Eighty-
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five percent of HIV negative women who intended to use contraceptives at baseline and 
did a 14-week visit (327/385) actually used contraceptives post-partum. One hundred 
thirty three HIV negative women did not intend to use contraceptives at baseline but 
reported contraceptive use post-partum. Therefore 83% of HIV negative women who did 
not intend to use contraception post-partum did use contraception post-partum (133/160). 
Similarly, 191/222 (86%) HIV positive women who intended to use contraceptives and 
did a 14-week visit reported post-partum contraceptive use. For HIV positive women, a 
large number of women who did not intend to use contraceptives at baseline reported 
post-partum contraceptive use (68/78; 87%). These analyses also suggest that intentions 
do not predict post-partum contraceptive use very well in this population.  
 Other researchers found intention to use contraceptives post-partum did not 
predict contraceptive use. Authors of a study in Madhya Pradesh, India of women of 
reproductive age found that over half of women intending to use contraception did not 
use contraceptives later (104). The author of a qualitative study in peri-urban Maputo, 
Mozambique found disjunctions between intentions to use contraceptives and actual use, 
and that contraceptive intent and use was influenced by gender divisions, informal social 
interactions and societal views about fertility (105).  I examined a component of Fishbein 
and Ajzen’s Theory of Reasoned Action that posits that individual intentions directly 
influence future behaviors (82, 83). However, I found in Model 1 that intent did not 
predict behavior. This result may be due to women’s changing fertility and reproductive 
health desires over time.  Indeed, women’s ambivalent reproductive intentions make 
prediction of contraceptive use difficult (50, 106).   
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 When I examined the direct (not moderating) relationship between HIV status and 
post-partum contraceptive use without intentions, I found that HIV status does predict 
post-partum contraceptive use in Models 2A and 2B. I found that the odds of condom use 
at 14 weeks post-partum were greater for HIV positive women compared to HIV negative 
women, and the finding was statistically significant. Further, HIV positive women had 
greater odds of dual protection compared to HIV negative women, and this finding was 
statistically significant. Authors of a prior study of PMTCT attendees in KwaZulu-Natal 
also found that the odds of condom use were higher for HIV positive compared to HIV 
negative women (28). The findings from Model 2 and the previous study suggest that 
HIV status is an important predictor of contraceptive use post-partum in PMTCT 
populations. Using Protection Motivation theory, I hypothesized that the threat of HIV 
positive status would prompt women to adopt an adaptive response (e.g. increase the 
odds of contraceptive use post-partum) compared to HIV negative women. My results 
suggest that women in this population did adopt an adaptive response (contraceptive use) 
when they received threatening health information (HIV positive status) (94, 95).  My 
findings also indicate that PMTCT interventions to prevent unintended pregnancies in 
HIV positive women are working in this population. However, it is important to note that 
contraceptive use, and particularly condom use and dual protection, are as important for 
HIV negative women of reproductive age as for HIV positive women of reproductive age 
because the risk of HIV infection for women of this age group is very high (98, 107). 
The measure of unwanted fertility in this study did not predict intent to use 
contraceptives in the future. In fact, women who experienced unwanted fertility were less 
likely to report intent to use contraceptives in the future than women who had not 
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experienced unwanted fertility; however, this finding was not statistically significant. 
Further, unwanted fertility experience was associated with reduced odds of contraceptive 
use at 14-weeks, and this was statistically significant. One possible explanation is women 
who experienced unwanted fertility are poor contraceptive users; having already had 
more children than a stated ideal. Therefore these women may be less likely to intend or 
to use contraceptives.  HIV status did not appear to moderate the relationship between 
unwanted fertility and intent or actual contraceptive use.  These findings do not support 
Protection Motivation Theory that the threatening health information of unwanted 
fertility and HIV positive status resulted in an adaptive response (94, 95). 
The measurement of unwanted fertility in this population was likely not a very 
good one. To measure unwanted fertility I used a method developed by Lightbourne to 
calculate whether actual family size exceeds a stated ideal family size at the time of 
conception (49-51). A limitation of this method is “rationalization,” or stating an ideal 
number of children close to the actual number of children. This happens because women 
are reluctant to report having “unwanted” children, and will bias estimates of unwanted 
fertility down (49, 50). Rationalization is a possible explanation of the skewed 
distribution and the reduced odds of contraceptive intent and use. Researchers in India 
used the Lightbourne method to measure unwanted fertility in a population of rural 
women of childbearing age and found that the desire to stop childbearing was 
significantly higher for women who had experienced unwanted fertility compared to 
women who had not (50). Up to a quarter of pregnancies in South African women are 
unwanted, therefore the measure of unwanted fertility in this population likely 
underestimated unwanted fertility (14).   
 45 
Limitations 
 Three hundred twenty six participants did not return at 14 weeks and 20 
participants refused to test for HIV during the study. On demographic characteristics 
included in the models, participants lost to follow-up were similar to participants who 
completed a 14-week visit, except for HIV status. Women lost to follow-up were more 
likely to be HIV positive. HIV status appears to affect post-partum contraceptive use in 
this study and others; therefore the loss of 326 participants may potentially bias the 
models. The measure of unwanted fertility may not accurately capture women’s 
experience with unwanted fertility due to rationalization. I wanted to include measures of 
ART use and exclusive breastfeeding. Due to missing values on ART use, I did not 
include it in the models.  The measurement of breastfeeding was not exclusive 
breastfeeding, so I did not include in the models.  
Conclusion 
 I sought to understand how intent to use contraceptives, unwanted fertility 
experience and HIV status affect women’s intent to use contraceptives and actual post-
partum contraceptive use in an urban clinic in Durban, South Africa. In this setting where 
HIV is highly prevalent it is ever more important that women control the timing and 
limiting of births so as to preserve the health of the mother and child. As a PMTCT 
strategy, the South African government promotes the use of modern contraceptives to 
women in antenatal care. I found that women’s intent to use contraceptives did not 
predict post-partum contraceptive use and that HIV status did not have a moderating 
effect on this relationship. I did find that HIV status had a direct effect on post-partum 
condom use and dual protection.  HIV positive women were more likely to use condoms 
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and dual protection post-partum compared to HIV negative women. This indicates that 
PMTCT strategies are working in this particular setting, but also points to the importance 
of promoting these messages to HIV negative women as well. I also examined unwanted 
fertility experience and intent to use contraceptives and actual post-partum contraceptive 
use with HIV status as a moderating variable. Women experiencing unwanted fertility 
may have already been poor contraceptive users and still less likely to use contraceptives 
post-partum. Therefore, more research with this group of women is merited to understand 
whether they are in need of additional contraceptive counseling and advice. The measure 
of unwanted fertility likely underestimated unwanted fertility experience in this 
population given the high number of pregnancies reported at unplanned. Further research 
is needed to understand unwanted versus mistimed pregnancies in this population and its 
interaction with HIV status to further determine whether these women require more 
attention and counseling about post-partum contraceptive use.  
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Figure 2:  Analytic Sample 
 
 Baseline  
 
   
 
 
 
 
 
 
 
 
 
 
 14 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,480 
1,154 
 
326 women did not do a 
14-week visit 
878 
276 women not sexually 
active (N=275) or 
pregnant (N=1) 
846 
 
32 missing data on 
contraceptive use 
20 women refused HIV 
testing 
1,500 
Model 1 
N=821 
25 missing values 
Models 2A -2B 
N=821; N=808 
25 missing values-A 
38 missing values-B 
Model 3 
N=807 
39 missing values 
Model 4 
N=819 
27 missing values 
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Table 1: Key Independent and Dependent Variables for SAHAPS Participants 
who Tested for HIV (N=846) 
Variable HIV Positive (N=300) (35.5%) HIV Negative (N=546) 
(64.5%) 
Key Independent Variables 
Intends to use modern 
contraception post-
partum  
(baseline measure) 
Yes-222 (74%) 
 
No-78 (26%) 
Yes-385 (70.5%) 
 
No-161 (29.5%) 
Unwanted fertility 
(baseline measure) 
Yes-23 (8%) 
 
No-276 (92%) 
 
Missing-1 
Yes-30 (5%) 
 
No-514 (94%) 
 
Missing-2* 
Key Dependent Variables 
Modern contraceptive use 
at 14 weeks post-partum 
(14 week measure) 
(Modern methods: 
injectables, pills, intra-
uterine device, 
sterilization, male or 
female condoms, 
diaphragm) 
 
Yes-259 (86%) 
 
No-41 (14%) 
 
Yes-461 (84%) 
 
No-85 (16%) 
Condom use at 14 weeks 
post-partum 
(14 week measure) 
(Condom use is male or 
female condom use) 
 
Yes-133 (44%) 
 
No-167 (56%) 
 
Yes-153 (28%) 
 
No-393 (72%) 
Dual protection at 14 
weeks post-partum 
(14 week measure) 
(Use of a male or female 
condom plus injectable, 
pill, intra-uterine device 
or sterilization) 
 
Yes-66 (22%) 
 
No-235 (78%) 
 
Yes-66 (12%) 
 
No-480 (88%) 
Intent to use 
contraception in the next 
12 months at 14 weeks 
post-partum 
(14 week measure) 
 
Yes-271 (90%) 
 
No-33 (10%) 
 
Yes-487 (89%) 
 
No-55 (11%) 
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Table 2: Control Variables for SAHAPS Participants who Tested for HIV 
Variable HIV Positive-N=300 
(% of HIV positive women) 
HIV Negative-N=546 
(% of HIV negative women) 
Age 26 years 
(range: 18-44 ) 
Missing-2 
25  years 
(range: 18-45) 
Education Level Primary or less-23 (8%) 
Grades 8 to 11-146-(49%) 
Matric-117 (39%) 
Beyond matric-13 (4%) 
Missing-1 
Primary or less-30 (5%) 
Grades 8 to 11-204 (37%) 
Matric-285 (52%) 
Beyond matric-27 (5%) 
 
Primary language Zulu-267 (89%) 
Xhosa-27 (5%) 
English/Other-6 (2%) 
Zulu-496 (91%) 
Xhosa-42 (8%) 
English/Other-8 (1%) 
Religion Christian-299 (76%) 
Traditional/African-55 (18%) 
Other-16 (5%) 
 
Christian-444 (82%) 
Traditional/African-71 (13%) 
Other-28 (5%) 
Missing/Refused-2 
Marital status Married-12 (4%) 
Partner-living together-83 (28%) 
Partner-not living together-205 
(68%) 
Married-49 (9%) 
Partner-living together-108 (20%) 
Partner-not living together-389 
(71%) 
 
Relationship 
duration 
4 years 
(range: 0.5-3.5) 
 
5 years 
(range: 0.5-26) 
Missing-1 
Employment status Housewife-132 (44%) 
Employed-139 (46%) 
Student-22 (7%) 
Unemployed-7 (2%) 
Housewife-238 (44%) 
Employed-210 (38%) 
Student-85 (16%) 
Unemployed-13 (2%) 
Partner has tested 
for HIV 
Yes-80 (27%) 
No/Don’t know-220 (73%) 
Yes-208 (38%) 
No/Don’t know-338 (62%) 
Age at first sex 18 years old 
(range: 12-26 ) 
18 years old 
(range: 11-34) 
Number of sex 
partners 
2.9 (range: 1-10) 
Missing-1 
2.3 (range: 1-28) 
Missing-1 
Other female 
household members 
Yes-195 (66%) 
No-100 (34%) 
Missing-5 
Yes-392 (73%) 
No-147 (27%) 
Missing-7 
Socio-economic 
status-Number of 
household assets 
5.0 (range:  0-9) 
Missing-1 
5.3 (range: 0-9) 
Missing-52 
Ever contraceptive 
use 
Yes-190 (63%) 
No-110 (37%) 
 
Yes-352 (65%) 
No-193 (35%) 
Missing-1 
Parity One birth-100 (33%) 
Two births-130 (43%) 
Three or more births-70 (23%) 
One birth-219 (40%) 
Two births-193 (35%) 
Three or more births-134 (25%) 
SAHAPS 
Intervention Arm 
Intervention-159 (53%) 
Control-141 (47%) 
Intervention-279 (51%) 
Control-267 (49%) 
 
*Does not equal 100% due to rounding 
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Table 3: Results from Logistic Regression Models 
 
 
 Model 1 (N=821) 
Modern 
contraceptive use 
at 14 weeks 
Model 2A 
(N=821) 
Condom use 
at 14 weeks 
Model 2B 
(N=808) 
Dual 
protection at 
14 weeks 
Model 3 
(N=807) 
Intent to 
use 
modern 
contracept
ives 
Model 4 
(N=819) 
Modern 
contracepti
ve use at 14 
weeks 
 Odds Ratio (Robust Standard Error)  
Intends to 
use modern 
contraceptio
n 
0.87 
(0.24) 
- - - - 
Unwanted 
fertility 
- - - 0.65 
(0.41) 
0.33* 
(0.19) 
HIV status 1.23 
(0.52) 
2.26* 
(0.39) 
2.27* 
(0.52) 
1.00 
(0.26) 
1.05 
(0.25) 
HIV status x 
Intent to use  
contraceptive
s 
0.82 
(0.40) 
(Ratio of odds 
ratios) 
- - - - 
HIV status x 
Unwanted 
fertility  
- - - 2.82 
(3.57) 
(Ratio of 
odds ratios) 
2.07 
(1.75) 
(Ratio of 
odds ratios) 
Age 1.02 
(0.03) 
1.00 
(0.02) 
1.00 
(0.03) 
0.97 
(0.03) 
1.01 
(0.03) 
Primary 
education or 
less 
0.77 
(0.37) 
0.40* 
(0.15) 
0.62 
(0.31) 
1.53 
(1.00) 
0.78 
(0.37) 
Grades 8 to 
11 
1.20 
(0.27) 
0.75** 
(0.13) 
0.84 
(0.20) 
0.94 
(0.24) 
1.19 
(0.27) 
Matriculatio
n 
Referent Referent Referent Referent Referent 
Higher than 
matriculatio
n 
1.21 
(0.59) 
1.57 
(0.55) 
1.12 
(0.48) 
3.74 
(3.98) 
1.24 
(0.61) 
Zulu Referent Referent Referent Referent Referent 
Xhosa 1.27 
(0.51) 
1.49  
(0.42) 
1.14 
(0.41) 
0.94 
(0.42) 
1.30 
(0.53) 
English/Othe
r 
0.32 
(0.19) 
0.13* 
(0.13) 
Omitted 
(N=13) 
0.73 
(0.57) 
0.31* 
(0.18) 
Christian Referent Referent Referent Referent Referent 
Traditional/
African 
0.87 
(0.26) 
0.90 
(0.21) 
1.11  
(0.34) 
0.75 
(0.22) 
0.86 
(0.26) 
Other 
Religion 
0.65 
(0.28) 
0.77 
(0.28) 
0.84 
(0.38) 
0.96 
(0.53) 
0.63 
(0.27) 
Partnered-
living 
together 
1.13 
(0.35) 
1.27 
(0.30) 
1.22 
(0.35) 
1.01 
(0.42) 
1.16 
(0.36) 
Partnered-
not living 
together 
Referent Referent Referent Referent Referent 
Married 0.94 
(0.45) 
0.68 
(0.25) 
0.56 
(0.27) 
0.61 
(0.33) 
0.91 
(0.45) 
Relationship 
duration 
 
0.99 
(0.03) 
1.01 
(0.025) 
1.03 
(0.03) 
0.98 
(0.04) 
0.99 
(0.04) 
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*Statistically significant p=0.05 **Statistically significant at p=0.10 
 
 
 
 
 
 
 
 
 
 
 Model 1 (N=821) 
Modern 
contraceptive use 
at 14 weeks 
Model 2A 
(N=821) 
Condom use 
at 14 weeks 
Model 2B 
(N=808) 
Dual 
protection at 
14 weeks 
Model 3 
(N=807) 
Intent to 
use 
modern 
contracept
ives 
Model 4 
(N=819) 
Modern 
contracepti
ve use at 14 
weeks 
Housewife Referent Referent Referent Referent Referent 
Employed 0.59* 
(0.13) 
1.02 
(0.18) 
1.02 
(0.24) 
0.90 
(0.24) 
0.60* 
(0.14) 
Student 0.51* 
(0.16) 
1.18 
(0.31) 
0.79 
(0.27) 
0.88 
(0.33) 
0.51* 
(0.16) 
Unemployed 0.77 
(0.47) 
0.76 
(0.41) 
1.17 
(0.72) 
1.07 
(1.18) 
0.78 
(0.44) 
Partner has 
tested for 
HIV 
0.79 
(0.17) 
0.90 
(0.15) 
0.88 
(0.19) 
1.09 
(0.29) 
0.82 
(0.18) 
Age at first 
sex 
0.94 
(0.04) 
0.98 
(0.04) 
1.06 
(0.05) 
1.10 
(0.07) 
0.94 
(0.04) 
Number of 
sex partners 
0.98 
(0.04) 
1.04 
(0.05) 
0.94 
(0.06) 
0.97 
(0.05) 
0.97 
(0.04) 
Other female 
household 
members 
0.98 
(0.26) 
0.76 
(0.17) 
0.75 
(0.21) 
1.21 
(0.45) 
1.02 
(0.28) 
Socioeconom
ic status 
1.02 
(0.06) 
1.11* 
(0.05) 
1.13* 
(0.07) 
1.01 
(0.07) 
1.03 
(0.06) 
Ever 
contraceptive 
use 
1.49* 
(0.31) 
1.88* 
(0.32) 
2.78* 
(0.68) 
1.09 
(0.28) 
1.48* 
(0.31) 
One birth 0.98 
(0.25) 
1.22 
(0.24) 
1.31  
(0.34) 
Referent 0.98 
(0.25) 
Two births Referent Referent Referent 1.40  
(0.45) 
Referent 
Three or 
more births 
1.67 
(0.59) 
1.14 
(0.27) 
0.93 
(0.29) 
1.10 
(0.52) 
2.11* 
(0.80) 
SAHAPS 
Intervention 
0.88 
(0.18) 
0.95 
(0.15) 
0.81 
(0.17) 
0.74 
(0.18) 
0.89 
(1.75) 
 
 
 
 
 
Chapter 5: Qualitative Methods and Results 
 
Methods 
Interview Procedures 
Interviewers purposively recruited fourteen family planning clients by HIV status 
(8 HIV negative; 6 HIV positive). All women were legal adults (18 years or older), had 
experience with family planning at the clinic and gave informed consent. I developed a 
semi-structured in-depth interview guide in Zulu with the help of local staff. All 
interviews were conducted in Zulu by a trained interviewer and tape-recorded. Interviews 
lasted from 30-60 minutes. Tape recordings were transcribed and translated into English 
from Zulu.  
Five nurses were purposively recruited to participate in the study with the help of 
the local study staff and all were 18 years old or older and gave informed consent. Nurses 
interviewed promoted family planning post-partum. I developed a semi-structured in-
depth interview guide in English for nurses with the help of local staff. I conducted the 
interviews in English and they lasted 30-75 minutes. The in-depth interviews were tape-
recorded the interviews transcribed.  
Analysis 
I read all of the client and nurse transcripts together for initial theme 
identification. Then, I created a preliminary codebook drawn directly from the interview 
guides and emergent from the data. I hand-coded the transcripts using deductive coding 
primarily from the interview guide questions, although I also used some inductive coding 
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as well, representing themes that emerged from the interview data (108). The unit of 
analysis was the individual. Analyses of client interviews included exploring differences 
between HIV negative and HIV positive women’s experiences at the clinic.  
Results 
Demographics  
Clients 
The average age of participants in in-depth interviews was 29 (range: 18-36 years) 
and HIV positive women were older than HIV negative women on average (31 versus 
27). Women were highly educated, as all completed 10 to 12 years of schooling and 64% 
completed Matric, the high school equivalent in South Africa. Most women had one or 
two children (range: 1-3) and HIV positive women had more children on average (2.3 
compared to 1.6 for HIV negative women). One woman was married, one woman was 
single and the remaining 12 women were in relationships, but not married. Although 
women were not married, they were in relationships for an average of 4.8 years (range: 1-
17), and HIV positive women had been in a relationship for an average of 4 years and 
HIV negative women for 7 years.  
All but one woman (93%) reported current contraceptive use, and all 13 women 
were using an injectable contraceptive method. Four women specified that they were 
using the 3-month injectable (Depo-Provera) and one specified that she was using the 2-
month injectable (Nuristerate) and the other women did not specify the injectable type. 
Eleven of 14 (79%) women reported past contraceptive use. Five women used an 
injectable contraceptive method, two used contraceptive pills, three used condoms and 
one used contraceptive pills and condoms. All six HIV positive women used 
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contraceptives in the past (3 injectable contraceptives, 2 condoms and 1 injectable 
contraceptive and condoms). Five of eight (63%) HIV negative women used 
contraceptives in the past (2 injectable contraceptives, 2 contraceptive pills and 1 
condoms).  
Nurses 
 The nurses were an average 49 years old (range: 37-55) and four of the five 
nurses had been working as nurses for over 20 years (average for all five: 23 years, range 
6-31). Two nurses had worked at the clinic for over 20 years, and the others between 4 
months and two years.  
The Process of Family Planning Promotion and Provision  
Women arriving for family planning at the clinic register at the main clinic and 
then wait in the reception area of the main clinic until they are called in groups of 10-15 
to come to a separate building where they, along with other women there to immunize 
their babies, are seen by nurses who immunize babies and distribute family planning. All 
women coming for post-partum family planning wait with clients also seeking 
immunization and see the same nurses. Women coming for family planning for the first 
time receive education from a nurse in a group about the available contraceptive methods 
and then have an individual conversation with a second nurse. Women returning for 
family planning only meet with one nurse in a private room. All of the women 
interviewed were at the clinic for post-partum family planning.  Women are encouraged 
to come for post-partum family planning during antenatal care and at delivery. The post-
partum visit coincides with the immunization schedule of the baby and is a time when 
family planning is promoted as well. The family planning methods offered are two 
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injectable contraceptive methods, Depo-Provera and Nursisterate, as well as hormonal 
contraceptive pills and condoms. All contraceptive methods are free of charge. When I 
asked nurses and clients whether other methods should be offered, they didn’t think any 
other methods were necessary. I also asked whether stock-outs of available contraceptive 
methods were a problem and nurses and clients said it was never a problem. Women are 
given a family planning card where nurses write the contraceptive method of their choice 
and their return appointment dates.  
Factors Important to Client Satisfaction with Family Planning Services:  Waiting 
Times and Nurses Treatment of Clients  
 
The amount of time women waited for family planning services affected their 
reported satisfaction with services. When women waited for short periods of time, 10-15 
minutes, they were satisfied.  When they waited for long periods of time (hours) they 
were not as happy with the family planning services. Women reported that if you arrive 
early in the morning (7am) the family planning nurses attend to patients quickly. The 
nurses begin to see clients around 8am, and at that time, clients move quickly from the 
main clinic to family planning and are often seen in 10-15 minutes.  One woman 
described this:  
[The nurses] treated me very well. When you come to the clinic, you don’t wait 
for a long time. They are very fast to help you. When they start working you don’t 
wait more than ten minutes. They have good care. They are very hospitable.  
(Client #2, 20 years old, HIV negative, 1 child, 12 years of education) 
 
However, two women reported long waits when they were unable to get to the 
clinic first thing in the morning. One woman explained: 
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Sometimes, if you are not here early, they don’t attend to you. They forget that we 
are not the same. I live [in another part of the township] and sometimes…I come 
here after 10 [am].  They ask: ‘Why were you sleeping?’  We once came after 
10am, and we waited until 3:30pm, it was so slow.  
(Client #9, 32 years old, HIV positive, 3 children, 11 years of education) 
 
A different woman was frustrated because at her last family planning visit, the 
nurses were rushing in the afternoon and were not giving the patients optimal care 
because they had arrived at the clinic later in the day: 
The nurses asked me why I came in the afternoon. I told them that I forgot that it 
was the 16th and that was why I didn’t wake up early in the morning to come to 
the clinic. When I checked my card in the afternoon and saw that it was my date, I 
rushed and came late. [Because it was so late] the nurses didn’t have any time. I 
don’t want to lie to you; they didn’t have any time. Instead of asking us questions 
about how the injections were treating us, because they normally ask, they didn’t 
ask any of us, but they wrote down ‘she is happy’, where as I never said that at 
all. (Client #10, 27 years old, HIV positive, 1 child, 12 years of education) 
 
The nurses realized that sometimes patients wait a very long time in the clinic, but 
the nurses said that they were understaffed and overloaded with patients. One nurse 
described this situation:  
Clients want things to happen [immediately] but [sometimes] we are not fully 
staffed. So sometimes we’ll let the client know we are busy with someone else.  
But some people [lose patience]. Nurse #1 
 
A different nurse also acknowledged the long wait times and said that sometimes patients 
go to private doctors because it is quicker. She described this: 
Clients wait for a long time here at the clinic. Sometimes they go to private 
doctors and pay 20 Rand because it’s faster. Nurse #2 
 
Some women compared their experiences at the clinic to other clinics in the 
township and preferred the services of the study clinic because of their hospitable 
treatment of patients:  
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When you go to other clinics for contraception, the nurses treat you badly. They 
shout at you and say all sorts of things. But here, even if you missed [the date for 
the injection], they don’t ask you a lot of things; they do what they are supposed 
to do. I think they treat patients well here, I have never seen any abuse [of 
patients]. (Client #3, 34 years old, HIV positive, 3 children, 11 years of education) 
 
She also described how she was very comfortable with the nurses, and that if the service 
was poor, she would go elsewhere: 
I am satisfied with the care I receive here. If I was not satisfied, I would have 
changed clinics, because there are a lot of them. [Here I feel] at home. If I’m with 
a nurse here, it’s the same feeling as being with my mother or my sister. I can tell 
[the nurse] all my problems.  
(Client #3, 34 years old, HIV positive, 3 children, 11 years of education) 
 
When women reported that they were treated poorly or did not feel comfortable 
with the nurses, they were more likely to also report dissatisfaction with the family 
planning services.  One woman said it was because there were certain nurses with whom 
she did not feel comfortable: 
There are those [staff] for whom you feel like going to the back of the queue [in 
order to] see the staff who don’t [cause] problems. Sometimes you [wish] you 
knew who was on shift, otherwise, you can’t relax. You should be able to relax 
with the nurse and tell her when you have a problem. [The way it is now] you are 
scared to tell the nurse your problem if you have one.  
(Client #9, 32 years old, HIV positive, 3 children, 11 years of education) 
 
A different woman said that nurses shout at the patients and are impatient with clients, to 
the point that she was considering going to a different clinic:  
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I got what I came for, but my feelings were hurt.  I did not feel good. Sometimes 
when it is your date to attend the clinic, you think, I can’t talk to the nurses 
because they are always busy shouting [at the patients]. Sometimes I think [about] 
changing to another clinic. It is not my first time here, but it is my first time for 
family planning. When I’m here, I’m always [attended to by] the same people 
who don’t have time and who don’t know how to talk [to patients].  I think that a 
person who works with the public should have patience, no matter [what].  For 
example, if [the nurse] is tired and has been working the entire day, she must [still 
treat] people as humans who have brains. She must not treat people as if they have 
no brain, you see. [She must not treat you like] she is better than you, [or act like 
she is better than you, or shout at you].  
(Client #8, 23 years old, HIV negative, 1 child, 12 years of education) 
 
Variability in Length and Content of Nurse-Client Conversations Affects Clients’ 
Understanding of Family Planning Methods 
 
I asked women about their most recent conversation with a family planning nurse. 
Five of the 14 women said that the nurse spent time with them and explained how the 
injection works in the body, possible side effects, risk of pregnancy if they miss a dose, 
the importance of condom use for protection from sexually transmitted infections and that 
they should return to the clinic if they experience problems with their chosen method. 
One woman described her most recent conversation: 
The nurse told me that the injection does not [always] agree with [you], and  
[sometimes] you must come back and change the injection. The nurse said when 
you take an injection [some clients] get fat and [some] don’t develop anything 
[and some] bleed when using the injection.  We spoke about the risk of pregnancy 
if you don’t wait [to have sex] for 7 days.  You must wait 7 days for the injection 
to settle. After that, you can sleep with a man.  After the injection has settled, it 
protects you from pregnancy.  
(Client #5, 27 years old, HIV negative, 2 children, 10 years of education) 
 
 Nine of 14 women described very short conversations (2 to 5 minutes) with the 
nurses during which time the nurse usually only asked them what method they were using 
and then the nurse gave it to them. Women often didn’t know the name of the 
contraceptive method they were using, but described it as the 2 or 3-month injection or 
the pills.  One woman described her conversation with the nurse: 
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[The nurse] asked if I chose pills or the injection, I said the injection for 3-months 
and she wrote it down, and I got the injection. They don’t explain a lot of things; 
you just say the injection that you want or the pills that you want, that’s all.  
(Client #9, 32 years old, HIV positive, 3 children, 11 years of education) 
 
When asked whether nurses inquired whether clients experienced side effects, described 
the risk of pregnancy if they miss a dose, or discussed other family planning methods, 
five of the 14 women said no. Two women described their last conversations with the 
nurses:  
We did not talk about different family planning methods. She said I would get 
used to the injection. We did not get enough time to talk.  There was little that we 
spoke about, [she asked] me how the injection was treating me.  Maybe it was 2 
minutes. (Client #2, 20 years old, HIV negative, 1 child, 12 years of education) 
 
It’s just that here at the clinic they don’t explain.  You end up choosing an 
injection [but you have] no information about it. Even when things happen in your 
body, it takes time [for you] to realize that it’s a side effect from the injection, 
because you were never given an explanation [about] the good and the bad of [the 
injection]. (Client #8, 23 years old, HIV negative, 1 child, 12 years of education) 
 
Some women were afraid to ask the nurses questions about family planning because there 
was a sense that they would take up too much time and the nurses were busy. One woman 
explained:  
[I wanted to ask] What is the difference between the 2-month and the 3- month 
injection? Because I’ve never heard about it in the clinic, but I always hear about 
it elsewhere.  I was scared [to ask because the clinic] was full and there were 
people [waiting]. (Client #14, 18 years old, HIV negative, 1 child, 11 years of 
education) 
 
 I asked the nurses how many patients they see in a day and how much time they 
spend with each patient. The nurses said that they see between 20-30 patients per day and 
spend 2-5 minutes with each of them. They also said that depending on the patient’s 
problem, they sometimes spend more time with the patient, but that they feel pressured to 
see patients quickly. One nurse explained:  
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It is difficult. The number of patients is increasing due to the squatter camps. 
Sometimes when you see them you don’t do a proper examination because of 
overload. In a day, we see 80 [patients]. And yet we are four nurses. It’s supposed 
to be 30-40 minutes per patient. Sometimes [we don’t have time] to do the proper 
thing. We have to push [in order to see everyone]. Nurse #2 
 
 Nurses described their conversations with the clients about family planning. The 
nurses treated the younger and older clients differently as well as the first time acceptors 
of family planning and the repeat users. One nurse explained how they separate the 
younger and older women: 
To make family planning effective, you must separate the young women from the 
older women, so that the women feel comfortable. Your health education and 
explanation will be different for the different groups of women. Nurse #5 
 
For the younger clients, the nurses promote Nuristerate and for older women Depo-
Provera. This is because Depo-Provera causes amenorrhea and it can take longer for 
fertility to return after stopping the method.  
Normally, the Nuristerate is good for the young ones who have never conceived. 
The other one [Depo-Provera or Petrogen], sometimes when you want to fall 
pregnant, it takes [a long time]. We normally start new acceptors and those who 
have never conceived on Nuristerate. Nurse #2 
 
However, the nurses emphasized that it is the patient’s right to choose the method and 
that they advise them about all of the different methods, and the patient ultimately 
decides for herself.  The nurses also reported that they spend more time with the first time 
users because they must guide the patient in the process of choosing a method for the first 
time, and this requires more in-depth discussions. One nurse described this: 
When you are dealing with a patient who is coming for the first time, you have to 
spend more time with that patient because we have to tell the patient about the 
methods that we have, we look at the age of the patient, whether the patient is 
breastfeeding or not, whether the patient is HIV positive or not, so with those 
patients, we have to spend more time, especially when they are coming for the 
first [family planning] visit. Nurse #3 
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Menstruation:  An Unnecessary Barrier to Family Planning Initiation 
 
Six clients mentioned that a woman must be menstruating in order to initiate a 
contraceptive method at the clinic. These women said that if a woman is not menstruating 
the nurses send them home and tell them to come back when they are menstruating. One 
woman described this: 
The nurses don’t let you take birth control before they can see that you are on 
your period. (Client #6, 32 years old, HIV positive, 2 children, 11 years of 
education) 
 
You have to go [to the clinic] when you are still on your period. You [can’t] just 
go there [any time]. [The nurses] want [clients] who are menstruating to [confirm] 
that they are not pregnant [before they start them on a contraceptive method]. 
(Client #8, 23 years old, HIV negative, 1 child, 12 years of education) 
Three of the five nurses interviewed said that clients must be menstruating in 
order to initiate a family planning method at the clinic. One of the nurses described this:  
If it is her first time using family planning, she must wait for her period and then 
come to do family planning. Nurse #3 
 
However, another nurse mentioned that nurses should not do this and that they should not 
turn away the clients because they are not menstruating: 
You must not dispatch the patients without a contraceptive method. Nurses have 
got it [in their minds] that the clients must be on their periods to start a 
contraceptive method. Then the patient will leave, have sex with her boyfriend 
and get pregnant.  Bleeding or not, give the patient a contraceptive method [at that 
moment]. Even if you give the patient an injection when the patient is pregnant, 
that injection is not going to harm anything. Nurse #5 
 
The Importance of Discussing and Understanding the Side Effects of Family 
Planning Methods 
 
 Ten of fourteen women interviewed reported 1-3 side effects when they used an 
injectable contraceptive method. Seven women described bleeding ranging from spotting 
to heavy bleeding for up to a month. Five of the seven women who experienced bleeding 
discussed it with a nurse, and one switched methods, another took pills to stop the 
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excessive bleeding, for one woman the bleeding resolved on its own, and for two women 
they were waiting to see if the bleeding normalized. One woman was not informed that 
bleeding was a possible side effect of Depo-Provera: 
The first time I used Depo. With my ignorance, I bled for a month. When I came 
back to the clinic, I explained that the injection induced bleeding. [The nurses] 
asked me why I hadn’t come back to tell them that I had a problem with bleeding.  
It was clear that I had not been well informed.   
(Client #3, 34 years old, HIV positive, 3 children, 11 years of education) 
 
Another woman was aware of the possible side effect of bleeding and was able to resolve 
the issue when she told the nurse:  
I bled a lot when I first started using contraceptives.  I bled for a long time, about 
two weeks, but after that, it stopped. [The nurses] explained to me that I might 
bleed a lot, but that it’s not a problem.  If I bleed a lot [the nurses explained] I 
should come to them so that they can give me the pills to stop the bleeding.  
(Client #10, 27 years old, HIV positive, 1 child, 12 years of education) 
 
The other two women who experienced bleeding did not say anything to the nurses, and 
one of them was in need of advice:  
If [there was] something that would [return] my period back to being normal. But 
I’m not sure if that is possible.  
(Client #14, 18 years old, HIV negative, 1 child, 11 years of education) 
 
Three women experienced weight gain and stopped getting their period, and one 
woman also experienced excessive bloating. One of the three women who gained weight 
told her sister, but not the nurse.  She remained on the method. Another woman whose 
period stopped and she gained weight and had excessive bloating just stopped using 
contraception:  
I am the one who… what can I say? I wasn’t having my period and I was gaining 
weight, so I thought I should stop for a while. [The injectable] makes you hungry, 
you gain a lot of weight and your body gets full of water.  
(Client #13, 25 years old, HIV positive, 2 children, 12 years of education) 
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 All of the nurses said they counsel their clients about the side effects of family 
planning. In particular, they said that they emphasize the side effect of bleeding and 
educate the women about what to do if they experience this side effect. One nurse 
explained:  
When they first come, we tell them the pill or the injection might cause them to 
have severe menses. We tell them that if they menstruate for more than 7 days, 
they must come back. But if you see [the menses] coming and going, or spotting, 
that is a normal thing, or stopping. But they know. It doesn’t scare them, because 
they know that it is the side effect from the injectable or pills. Nurse #1 
 
Nurses also said that they educate about the side effects of headache and weight gain. 
One nurse thought it was important to discourage changing methods if clients experience 
side effects:  
The most common side effect is the headache, the weight gain. Educate. Don’t 
say ‘Change the method’, educate. Stay on the method. Unless there are severe, 
severe side effects. Nurse #3 
 
Whereas another nurse cautioned against not switching the client’s method because the 
client might stop taking contraception and then get pregnant:  
Tell them contraindications. Don’t just say this [contraceptive method] is fine. 
Tell them about the side effects. When patients experience side effects, you 
counsel them. And then [depending on the patient] you change the method. If [the 
method] causes her to bleed, you cannot say: ‘Continue! Continue!’ Because you 
don’t want [her to stop the method and get pregnant]. Nurse #5 
 
Another nurse also pointed out that if patients experience side effects, they don’t always 
return to the clinic and just discontinue their contraceptive method.  She described this: 
The patients don’t always come back when they have side effects. They just stop 
taking the method. Nurse #4 
 
The Importance of Discussing HIV Status and Family Planning 
                                                                                                                                                                                                                                                                                                                            
 Of the six HIV positive women interviewed, the nurses discussed with four 
women their HIV status as part of their last family planning counseling session. The 
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nurses who discussed women’s HIV positive status supported their use of family 
planning, but also emphasized the importance of condom use and ART prophylaxis to 
them. Two of the women who discussed their HIV positive status described their 
experience:  
The nurse said that if I know my status I must look after myself and use a 
condom. And because I am on contraception [I must not] stop using a condom. 
She said we must use condoms because we know our [HIV positive] status.  
(Client #6, 32 years old, HIV positive, 2 children, 11 years of education) 
 
She said that the [contraceptive] injection is not as important [as the condom] 
because I know my situation (that she is HIV positive). I should not [stop using] 
the condom. I am all right (she is on treatment) and I must stay on treatment so 
that my CD4 count does not go down.  
(Client #3, 34 years old, HIV positive, 3 children, 11 years of education) 
 
The two HIV positive women who did not discuss their HIV status with the nurses at the 
clinic wanted more information about how HIV and contraception affect their bodies. 
One woman explained:  
(Interviewer: Did the nurse say anything about your HIV status when you 
discussed contraception?) She never asked me about my [HIV] status.  [The 
nurses] must [give us the] proper information.  Like those of us who are HIV 
positive, they must explain to us, because there are those of us without [the right] 
information.  If they could explain about family planning, what they are going to 
do, why they are doing it, how is it going to protect you and what is it going to do 
in your body. (Client #11, 36 years old, HIV positive, 3 children, 12 years of 
education) 
 
 For the eight HIV negative women, four did not discuss their HIV status with a 
nurse as part of the family planning counseling, three did, and there was no information 
for one woman. One woman who did not discuss her HIV status with a nurse did discuss 
the importance of condom use in addition to the injection:  
[The nurse] said even if you are on contraception it is important to use condoms 
because the injection does not prevent HIV, it prevents pregnancy.  
(Client #5, 27 years old, HIV negative, 2 children, 10 years of education) 
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Although one of the women told the nurse her HIV negative status, the nurse simply 
noted it, but did not discuss it with her: 
(Interviewer: Is there anything that the nurse said about your HIV status when you 
were talking about family planning?)  She asked if I checked my HIV status, and I 
said yes. She asked:  ‘What were the results?’ So I said they told me I was 
negative. Then she wrote other things, and then I went to be injected.  
(Client #8, 23 years old, HIV negative, 1 child, 12 years of education) 
 
Another nurse emphasized that even though the patient knows that she is HIV negative, 
she must still use condoms: 
(Interviewer: Did the nurse say anything about your HIV status when you 
discussed family planning methods?)  Yes. My status was negative. [The nurse] 
told me I must not stop [using] condoms because a man goes all over. If I stop 
using condoms because I think I trust my partner, I [still] don’t know what he is 
up to. I’ll have sex with him, trusting him and knowing that I’m HIV negative; 
then I [might] get infected. Therefore, I must not stop using condoms.  
(Client #7, 26 years old, HIV negative, 1 child, 12 years of education) 
 
 Two nurses reported that they promote contraceptives the same way to HIV 
positive and to HIV negative patients. One of these nurses explained: 
We promote contraceptives the same way to HIV negative and HIV positive 
patients. If they are HIV negative they can still be exposed to HIV. And those 
who are HIV positive, they are supposed to use contraceptives, especially 
condoms, because they prevent STIs and pregnancy. Everyone must use 
contraceptives, condoms. If you don’t use condoms and you use [hormonal] 
contraceptives, you can get HIV. Use both [hormonal contraceptives and 
condoms]. Nurse #4 
 
Two other nurses described differences in how they promote family planning to HIV 
positive and HIV negative clients. One nurse explained how family planning is promoted 
to HIV positive patients:  
Those who are HIV positive we don’t give the 2-months [injection], the short 
acting one, rather we give the 3-months or long acting one. Because of contra-
indication of the [ART] treatment, you cannot give a patient who is HIV positive 
the Tri-phasal, the Nordette, because the effect of the [contraceptive] tablets is 
reduced if the patient [is taking ART treatment]. Nurse #3 
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Tri-phasal and Nordette are contraceptive pills that do interact with ART drugs to lower 
contraceptive effectiveness.  Another nurse described the importance of condom use for 
HIV positive patients, but also the difficulty of convincing HIV positive patients to use 
condoms. She explained:  
The HIV positive patients, we advise them to use condoms. They say [condoms] 
are uncomfortable, I’m going to die anyway, so [I’d rather have] ‘flesh on flesh’ 
[sex]. We discourage ‘flesh on flesh’ and still encourage them to use condoms. 
They say they don’t enjoy sex with a condom. There are people who say ‘I’d 
rather die than use a condom’. Nurse #2 
 
Condoms Should be Discussed with All Clients 
 
 I asked women whether nurses discussed condoms during their last family 
planning counseling session. A majority of women discussed condom use with a nurse 
(11/14; ~79%), whether they were HIV positive (5/6; 83%) or HIV negative (6/8; 75%). 
Nurses emphasized with women in the counseling sessions that injectable contraceptives 
do not protect them from HIV or other STIs. One woman described her session, including 
a condom demonstration: 
(Interviewer: Did the nurse talk about condom use?) [The nurse] showed us how a 
condom is used.  The condom protects you from falling pregnant and protects you 
from sexually transmitted diseases. The nurse showed us how it works and how to 
throw it away. (Client #7, 26 years old, HIV negative, 1 child, 12 years of 
education) 
 
For HIV positive patients, nurses emphasized the importance of condom use at all times 
with their partners. One woman explained: 
(Interviewer: Did the nurse say anything about the use of condoms?)  Yes, she 
did.  She said that if you know your [HIV] status is positive, you must [have sex 
using] a condom at all times. She said that whenever you [have sex] with your 
partner, you must always use a condom. 
(Client #13, 25 years old, HIV positive, 2 children, 12 years of education) 
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Nurses also emphasized condom use with HIV negative women, particularly if they have 
multiple partners. An HIV negative woman described her session: 
(Interviewer: Did the nurse talk about condom use?)  Yes. She said you should 
condomize. If you have multiple partners you must condomize, because you don’t 
know where your partners have been.  
(Client #1, 35 years old, HIV negative, 3 children, 12 years of education) 
 
 All of the nurses said that they promote condoms to all clients, whether they are 
HIV positive or HIV negative. Nurses give out condoms free to all clients and 
demonstrate their proper use. Two nurses described this:  
Every client, we tell them about condoms and give them condoms, whether they 
ask for them or not. Nurse #2 
 
To promote condoms, we put them everywhere. The condoms are free for them to 
take. I demonstrate how to use a condom. Nurse #4 
 
All of the nurses also explained that they promote condoms as a method to 
prevent sexually transmitted diseases, including HIV, but not as a family planning 
method. The nurses acknowledged that condoms are indeed a family planning method, 
but as a health education strategy, they promoted hormonal contraceptives for family 
planning and condoms for STI prevention as a means to encourage the use of both. Two 
nurses explained this strategy: 
Normally the condom is not for preventing them from getting pregnant; that is 
what we emphasize. Because what if it bursts? Because they tell us ‘Oh [the 
condom] burst’. We say to them if you were taking tablets or injections you 
wouldn’t be pregnant. The condom is for STIs only, not for preventing you from 
getting pregnant. Nurse #1 
 
So I cannot say condoms are one of the methods of contraception, because when 
you say a condom is a method of contraception, the client will say nurse, I don’t 
want to take Petrogen, I don’t want to take Nuristerate; I’ll use a condom. When 
you know very well that there will be that day when the patient will not use the 
condom. So never ever mention the condom as a contraceptive. Mention the 
condom as prevention for HIV/AIDS and STIs. Nurse #3 
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Although the nurses encouraged clients to use condoms and educated them about 
their proper use, they understood the challenges clients face when using condoms 
because their male partners are often opposed to condom use and because women are 
often submissive to men and unable to request condom use. Two nurses described this: 
There are challenges with condom use. The clients say their husbands, their 
boyfriends; they don’t want to use a condom. That is why there are so many 
people who are HIV positive. Nurse #2 
 
[Women] tend to be submissive. Because they think that if the man doesn’t want a 
condom, and they insist, he will leave them for another woman. So they tend to 
allow everything, even if it’s harmful to them.  Nurse #1 
 
Another nurse described the importance of educating men about condom use: 
It is not enough to educate women [about condom use] because they are inferior 
[to men]. Those [men] who are superior, they won’t allow women to use a 
condom during sex. It is very important to educate young men. Even the older 
men. Nurse #4 
 
Missed Opportunities and Misinformation about Sterilization as Another Family 
Planning Method 
 
 I asked women whether the nurses at the clinic ever discussed sterilization with 
them. Sterilization is not offered at the clinic, but women are referred to a nearby hospital 
for the procedure. Half of the women were interested in sterilization, yet none of them 
spoke with a nurse at the clinic about it. One woman explained: 
I first heard [about sterilization] at [the hospital]. The doctor was talking to 
someone next to me.  [Their conversation] made me realize that sterilization is 
important.  It’s something that I always imagined as painful. I’m scared of 
anything that involves the uterus. I never heard [about sterilization] here [at the 
clinic].  (Client #9, 32 years old, HIV positive, 3 children, 11 years of education) 
 
 Five women were afraid of sterilization for different reasons. Two women were 
afraid that it wouldn’t work.  One woman explained: 
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At the hospital I told the doctor to sterilize me because I did not wish to have 
another baby.  I was talking to another lady and she said ‘I sterilized but here is 
the baby’.  She had two children and decided not to have another, so she 
sterilized. So then I also wanted to be sterilized, but I was scared. Now I’m 
worried because [if I do sterilize] I have no way to check to see if I was really 
closed. (Client #3, 34 years old, HIV positive, 3 children, 11 years of education) 
 
The other women were afraid that sterilization would make them sick and were not clear 
how the procedure was done. One woman described her fears:  
I am afraid.  I heard from ladies that are sterilized that it makes you sick.  When 
you get the operation, [they] close the uterus inside and it makes you sick in the 
blood; that is what scares me.  
(Client #5, 27 years old, HIV negative, 2 children, 10 years of education) 
 
 Three women believed that you could not sterilize until you have three or four 
children. One woman also thought that her husband had to agree for her to be sterilized: 
If you are going to sterilize, your husband should also agree. Once I asked a 
nurse, before I had this baby, if you are allowed to [sterilize], if you had a C-
section and you are pregnant with a fourth child.   She said yes, if you agree with 
your husband. You are able to [sterilize], but the law says [after] three [children] 
and sometimes four [children].  
(Client #1, 35 years old, HIV negative, 3 children, 12 years of education) 
 
 Despite women’s fears about sterilization, half of the women interviewed wanted 
more information about the procedure. One woman expressed multiple fears, but was still 
interested in sterilization and wanted more information from a medical professional:  
I have thought about [sterilization], but I was frightened because people say it’s 
scary.  I don’t know how it’s done…some operation on the side of the body?  I 
thought after having this baby, I would get sterilized. But I didn’t do it.  I was 
scared.  And there’s a girl who told me that she was sterilized, but she was always 
bleeding every month, and not just a little, but a lot.  I would like to hear more 
about sterilization from a doctor or a nurse.   
(Client #10, 27 years old, HIV positive, 1 child, 12 years of education) 
 
 Several nurses said that female sterilization is rare because of lack of knowledge 
on the part of the providers and the clients and lack of uptake.  Two nurses explained the 
lack of knowledge about the procedure: 
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It’s very rare [sterilization]. It’s a lack of knowledge on the part of the clients and 
the providers. The procedure is available. I would refer the patient to the hospital. 
I would first advise her. You want to give them time to think about it, because it’s 
not an easy procedure, because then she won’t be able to have a child for the rest 
of her life. Nurse #2 
 
It’s not common [for patients to ask for sterilization] because they don’t know 
[about it]. Nurse #5 
 
Another nurse perceived that patients weren’t interested in sterilization: 
 
Even if we talk to patients about tubal ligation, they don’t want to do it. Nurse #3 
 
 The nurses promote sterilization to older women with high parity or women who 
already had several C-sections. One nurse explained that sterilization if for higher parity 
women: 
Tubal ligation is a family planning method for those who have more babies. Let’s 
say you’ve had four babies or three babies. The mother will say nurse, ‘I don’t 
want any more babies. I’m tired of [taking] family planning’. You tell the patient, 
because you have so many babies, three is enough for you, I recommend that you 
do a tubal ligation. Nurse #3 
 
 Patients are told they must use hormonal contraceptives before they are 
considered for sterilization, because they must be referred by a nurse to the hospital. The 
length of time nurses told patients that they must first use family planning varied. Two 
nurses described this: 
We refer patients to the hospital for sterilization. Sometimes they ask what can I 
do if I don’t want to have any more babies. We advise them to do family planning 
first, for one year. Then we refer them to the hospital. Nurse #4 
 
When the patient asks for tubal ligation, we have to do so many things. First, the 
patient has to do family planning, for 6 or 7 months? I’m not sure [how long]. But 
the patient has to do family planning. She has to have a PAP smear. Once she 
does those things, we refer the patient to the hospital. Nurse #3 
 
Nurses were very reluctant to discuss sterilization with younger women because it is 
permanent, and they would rather the younger women use a reversible family planning 
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method until they are older or are higher parity. Nurses said they considered the patient’s 
age and marital status as part of discussing sterilization with a patient. One nurse 
explained the process: 
The process of sterilization…you check the [patient’s] age, you check the marital 
status also. You check the HIV status [of the patient] and you also check the 
mentality of the patient. And then you must explain when you sterilize someone 
they must sign a consent form [that they understand fully]. If you don’t tell the 
patient everything about sterilization, you as a nurse are going to be in trouble. 
Before, in the 1980’s, they used to tie the tubes. Now, because of [advances] in 
research, they cut the tubes. And it’s not easy to reconnect the tubes. Nurse #5 
 
Suggestions to Improve Family Planning Services 
 I asked women if they had any suggestions about how to improve the family 
planning services at the clinic.  Most of the women said that they were satisfied with the 
services and did not have any suggestions, however, eight women gave suggestions about 
how to make the family planning services at the clinic better. Five of the eight women 
who made suggestions said that the women attending the clinic for family planning 
should be separated from the women attending the clinic to immunize their babies.  
I wish that they would separate [the patients] coming for contraception from the 
mothers with babies, because sometimes you are in a rush [to get your 
contraception].  
(Client #11, 36 years old, HIV positive, 3 children, 12 years of education) 
 
One woman suggested that one nurse be dedicated to family planning only.  
They should separate the nurses. There should be one nurse for family planning 
and one nurse for immunization.  
(Client #6, 32 years old, HIV positive, 2 children, 11 years of education) 
 
The women who suggested these changes wanted the separation for expediency and for 
privacy.  
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The other three women suggested that the clinic staff needed to improve. One 
woman said she thought that the staff needed to learn to respect the clients more.  She 
described this: 
(Interviewer: Are there any changes you think should be made to improve the 
clinic?)  Educating the employees about respect…respecting other people. Maybe 
other things [would] automatically [improve]…because it all starts from respect. 
(Client #8, 23 years old, HIV negative, 1 child, 12 years of education) 
 
In a similar vein, another woman suggested that the staff not shout at the clients: 
 
They should limit their shouting…the way they shout at you and go crazy. They 
must limit shouting [at patients] and speak to us in a pleasant manner.   
(Client #13, 25 years old, HIV positive, 2 children, 12 years of education) 
 
Finally, one woman thought that the clinic needed more staff, and staff that are dedicated 
to their work and to the clients. She explained: 
They must find permanent staff that will work with passion, not casual staff.  I 
wish they would increase [the number of] staff. What is more important, is that 
clients should be looked after, and [with] no delays. 
(Client #9, 32 years old, HIV positive, 3 children, 11 years of education) 
 
 I asked the nurses how the clinic could improve to make their jobs promoting 
family planning easier. Four of the five nurses said that the clinic should have one nurse 
dedicated to family planning only, rather than several nurses who work on family 
planning and immunization. The nurses said that this would help with privacy and allow 
the nurse to have enough time with the family planning clients. One nurse explained: 
We don’t have a place where we have a family planning nurse [attending to 
family planning clients only]. It’s time consuming because someone will come 
with a card for family planning and bring a baby for immunization, so you have to 
do immunization and family planning and there is no privacy. If there was a room 
just for family planning, that would be better. Nurse #1 
 
Another nurse thought that they also needed more staff because they are too busy and 
don’t have enough time to adequately promote family planning. She explained: 
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We need to have more staff. Because you’ll find that sometimes we fail to 
promote contraception because we are rushing the queue. That’s the most 
important thing, the shortage of staff and the number of clients. I think for us to 
promote family planning we need to have more staff. We need to have a nurse 
who is responsible for family planning only. That is how we can effectively 
promote family planning. Nurse #3 
 
 One of the nurses discussed the importance of privacy, dignity and allowing the 
patients to ask questions. Dignity included not judging patients. She explained: 
Here at the clinic, we are caregivers, we are not mothers.  We are not the priest. 
We are caregivers. When you see a young girl come to the clinic in a school 
uniform, [nurses berate them], but we are not their mothers. We are not the social 
worker. We are caregivers. Don’t just shout [at her] and scold [her], she is not 
going to come back. Don’t treat her as if she is your own child. Do you think 
someone is going to ask for contraceptives if you just shouted at her?  That is why 
our clients are running away. Then the clients tell other people not to go to the 
clinic. Nurse #5 
 
She also stressed the importance of letting the patients talk and ask questions: 
 
You must let the patient ask [questions].  You can’t just talk and talk and talk. 
You must give them a chance to ask [questions]. Sometimes, if you just give them 
the method without telling them everything, for three or four days they are not 
safe [but they don’t know]. They will think they are protected [when they aren’t]. 
Nurse #5 
 
Finally, she emphasized that nurses must not shout at the patients because that is why 
patients do not come back: 
You must not shout. That is our problem. That is why our patients run away. Our 
attitudes as nurses. We must listen to the community and change our attitudes. If 
we don’t, we will continue to do the wrong things, and things will get worse [at 
the clinic]. Nurse #5 
 
Discussion 
 
 Clients and nurses reported variations in client waiting times and the amount of 
time they spent together during a family planning visit at the clinic.  The volume of 
patients at times affected the client-provider interaction time, and as a result, the quality 
of care. Patients were unable to ask questions or perceived that nurses were too busy to 
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answer them, and nurses reported that they felt rushed and didn’t always have sufficient 
time to address patient’s concerns. Other studies also find that where staff are 
overworked and clients wait for a long time, patient satisfaction and quality of care are 
decreased (74, 76, 79). The South African government’s national contraceptive policy 
guidelines include that all government clinics ensure reasonable waiting times for clients 
(109). In this study, I found that although the clinic was open 24 hours, clients who did 
not arrive early in the morning often had to wait for very long periods of time, where as 
those who arrived early were seen quickly and reported greater satisfaction with the 
family planning services.  
 Nurses promoted different contraceptives to younger and older clients. Nurses 
encouraged younger women to use Nuristerate and older women to use Depo-Provera. 
From the nurse’s perspective, Nuristerate was better for younger women because their 
return to fertility was quicker compared to Depo-Provera. In a society where fertility is 
highly valued, this makes sense (47). Depo-Provera also causes amenorrhea, which may 
be unacceptable to some younger women. Authors of other studies conducted in South 
Africa found that menstruation was important to women because it was a way for “dirty 
blood” to exit the body, and lack of menstruation was a reason for method 
discontinuation (65, 110). Use of Nuristerate has increased in South Africa, likely due to 
its promotion to younger women (65, 111). However, according to WHO guidelines, 
there is no reason based on age or parity alone why one injection should be preferred over 
the other, and the South African national contraceptive policy guidelines state that young 
women should not be prevented from using either injectable method because of their age 
(109, 112). I also found that clients were required to initiate contraceptive use during 
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their menstrual period to confirm that they were not pregnant. The South African national 
contraceptive policy guidelines clearly state that contraceptive use should not be 
restricted to menstruation because this creates an unnecessary barrier to access (109).  
 A majority of women in the study experienced side effects from injectable 
contraceptive methods. Most women discussed the possibility of side effects with a nurse 
when they initiated the method and returned to the clinic and were able to resolve their 
problems. However, several clients reported that the nurses never discussed side effects 
with them. Side effects are common with injectable contraceptive methods and can lead 
to discontinuation (66). Authors of studies in South Africa and other African countries 
also found that women who experienced side effects discontinued their contraceptive 
method (110, 113, 114). Effective counseling as defined in the South African national 
contraceptive policy guidelines includes providing complete information about the 
chosen method, including side effects and how to deal with them, and warning signs of 
complications and what to do if they occur (109). 
 Nurses were more likely to discuss HIV status with HIV positive women as part 
of their contraceptive counseling, however, nurses did not discuss HIV status at all with 
many clients interviewed. Some of the nurses said that they promoted family planning the 
same way to clients whether they were HIV positive or negative and some said that they 
promoted different methods to HIV positive women. Authors of a study in Ethiopia with 
voluntary HIV counseling and testing clients found that counselors were more likely to 
discuss reproductive health with HIV positive women (115). South Africa’s contraceptive 
policy guidelines state that providers should conduct an HIV/STI risk assessment with 
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clients as part of family planning counseling and promote dual protection, as necessary 
(109). 
 Even where nurses did not explicitly discuss the client’s HIV status, they did 
promote condom use. A majority of clients discussed condom use with nurses and nurses 
promoted condoms to clients regardless of their HIV status. In a population of women 
where the HIV prevalence exceeds 30% (116), condom promotion to every client is 
extremely important. Nurses promoted condoms as STI prevention, not as a family 
planning method, in order to promote dual protection with clients. Both nurses and clients 
mentioned the difficulties of condom use with male partners. The difficulty of getting 
men to use condoms has been well documented in South Africa and elsewhere (114, 117-
119). 
Many women in our study were interested in female sterilization but expressed 
numerous fears and misconceptions about the procedure. None of the women interested 
in sterilization discussed it with a nurse. The nurses said that there was lack of 
information on the part of the clients and the nurses and perceived that clients weren’t 
interested in the procedure. Patients are referred to a local hospital for the procedure, 
however, nurses were confused about whether the patient had to use contraception for a 
specified period of time before she could be sterilized and nurses were reluctant to 
promote sterilization to younger women. The South African Sterilization Act of 1998 
guarantees the right to sterilization for any consenting adult over the age of 18 (109).  
 A majority of women interviewed were satisfied with the family planning services 
they received at the clinic. Women liked the fast service, hospitable nature of nurses they 
interacted with and they were happy with their contraceptive methods. For clients who 
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were not satisfied with the services, they felt that the nurses were rushing and that nurses 
were impatient or demeaning to them.  
 When asked how family planning services at the clinic could be improved, clients 
and nurses thought that there was a need for more privacy for family planning clients and 
that a nurse (or nurses) should be dedicated specifically to family planning. The national 
contraceptive policy guidelines state that effective family planning counseling should be 
in a private, comfortable environment where client confidentiality is ensured (109). 
Nurses wanted more staff because they felt rushed and overworked and felt this would 
ensure better quality care. Nurses and clients thought that the staff needed to work harder 
to respect clients and not yell at them or demean them. As part of the national 
contraceptive policy guidelines, nurses should be trained in values clarification, anti-bias 
and the development of client rights, and provide services to all people in a respectful, 
understanding and nonjudgmental manner (109). 
This study is limited by its size and the findings should not be generalized beyond 
the study site. The findings are based on nurses’ and client’s self reported behaviors and 
may suffer from social desirability bias.  I tried to minimize this by interviewing clients 
in Zulu by trained interviewers who built rapport with interviewees and nurses in English 
by an interviewer with no influence in their professional development.  Despite these 
limitations, the findings from this study are useful for understanding the family planning 
experience from the client and the provider perspectives.  
Conclusion 
 I sought to understand family planning promotion from both the client and 
provider perspectives in a government clinic in an urban township in Durban, South 
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Africa. Overall, most clients were satisfied with the services they received at the clinic, 
particularly when they were expedient and hospitable. I did uncover areas where services 
could be improved. Women should be able to initiate a contraceptive method whether 
they are menstruating or not. Requiring clients to return to the clinic when they are 
menstruating creates an unnecessary barrier to family planning initiation. In a setting 
where HIV prevalence and unintended pregnancy rates are very high, it is imperative that 
nurses discuss with all clients their HIV status, contraceptive use and condoms for dual 
protection, not just some clients. Nurses and clients reported that lack of time and volume 
of patients impeded the ability of clients and providers to have needed conversations 
about family planning, including side effects. Clients and nurses suggested that increased 
privacy and a nurse dedicated to family planning might contribute to more time and better 
quality of care. Clients were interested in sterilization, but never discussed it with nurses. 
Nurses admitted that there was lack of knowledge about the procedure on their and the 
client’s parts. More efforts to educate both clients and nurses about sterilization and about 
the client’s right to undergo the procedure are merited. Finally, nurses and clients 
discussed the need for additional training of nurses in the respectful treatment of patients 
so that they feel comfortable at the clinic.  
 
 
 
 
 
  
 
 
Chapter 6: Conclusion   
 
 Utilizing mixed research methods in this dissertation I sought to: Aim 1: Examine 
whether knowledge of HIV status affects women’s modern contraceptive use post-
partum, Aim 2: Determine whether unwanted fertility and HIV status affect post-partum 
modern contraceptive use and intent and Aim 3: Explore health facility factors such as 
client-provider interactions around contraception, counselor’s knowledge about 
contraceptive methods, client waiting times and other health facility factors affecting 
modern contraceptive use post-partum.  
 Qualitative and quantitative findings from my dissertation suggest that knowledge 
of HIV status influences post-partum contraceptive use. The results from quantitative, 
multivariate Models 1 and 2 show that HIV status has a direct, but not moderating effect 
on post-partum contraceptive use.  HIV positive women were more likely than HIV 
negative women to use condoms and dual protection post-partum. This finding has 
important implications for PMTCT programs in South Africa. Women who test HIV 
positive during antenatal care are more likely to use contraceptives post-partum to 
prevent future pregnancies compared to HIV negative women. Many South African 
women do not know their HIV status until they test during pregnancy.  The findings from 
my dissertation support the importance of HIV testing during pregnancy as a motivating 
factor for HIV positive women to use contraceptives post-partum. Further, many HIV 
negative women who did not intend to use contraceptives at baseline ended up using 
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them post-partum. Prior research with this population suggests that HIV negative status is 
also a motivating factor to use modern contraceptives and remain HIV negative (91).   
HIV positive women may be more likely to adopt contraception post-partum 
because nurses are more likely to discuss the importance of condoms and dual protection 
with them. Qualitative findings from in-depth interviews revealed that nurses were more 
likely to discuss HIV status with HIV positive women as part of their post-partum 
contraceptive counseling, however, nurses did not discuss HIV status with many clients 
as required by the South Africa contraceptive policy guidelines. Even when nurses did 
not discuss HIV status with clients, they did discuss the importance of using condoms, 
although both clients and nurses acknowledged that condom use is difficult for many 
women because it involves male partners. In-depth interviews with nurses revealed that 
nurses promote condoms for STI prevention and hormonal methods as family planning as 
a strategy to encourage dual protection. In a setting where HIV prevalence and 
unintended pregnancy rates are high, it is imperative that nurses discuss with all clients 
their HIV status, contraceptive use and condoms for dual protection, not just some 
clients. 
Unwanted fertility experience did not predict intent to use contraceptives in the 
future and unwanted fertility experience and HIV status did not affect post-partum 
modern contraceptive use.  Women who experienced unwanted fertility were less likely 
to report intent to use contraceptives in the future than women who had not experienced 
unwanted fertility; however, the finding was not statistically significant. HIV status did 
not moderate the relationship between unwanted fertility and intent or actual 
contraceptive use.  Unwanted fertility experience was associated with reduced odds of 
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contraceptive use at 14-weeks. One possible explanation is women who experienced 
unwanted fertility are poor contraceptive users; having already had more children than a 
stated ideal. Therefore these women may be less likely to intend use contraceptives.  
However, the quantitative measure of unwanted fertility likely underestimated unwanted 
fertility experience in this population. In the most recent DHS, up to 25% of pregnancies 
in South African women of reproductive age were unwanted (14). Eighty percent of 
women in this study reported their pregnancy as unplanned, however, this is a different 
concept than unwanted, and an unplanned pregnancy may be wanted but mistimed. I was 
unable to distinguish between mistimed and unwanted pregnancies in this population, and 
perhaps mistiming of pregnancies is more important. Further research and measurement 
of pregnancy intentions is needed in this population in order to distinguish between 
mistimed and unwanted pregnancies.  
 Qualitative in-depth interviews with clients and nurses revealed factors at the 
health facility that influence in post-partum modern contraceptive use. These factors 
included client waiting times, duration and content of the client-provider interaction, 
staffing levels and patient overload, and knowledge of nurses and clients about modern 
contraceptive methods.  
 Clients who waited for shorter periods of time reported higher satisfaction than 
clients who waited for long periods of time. Even though the clinic is open 24 hours a 
day, the volume of patients affected the client-provider interaction time, which in turn 
affected the quality of care. Nurses reported feeling overloaded and clients reported 
feeling rushed. Clients and nurses suggested that one nurse be dedicated to family 
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planning only as a way to increase interaction time and improve quality and 
confidentiality.  
 Although many clients reported in-depth conversations with nurses about 
different family planning methods, side effects, risk of pregnancy and STIs, several 
clients did not discuss these topics with nurses, even though nurses said that they discuss 
these topics with all clients. This has important implications for client contraceptive 
adoption and continuation. A majority of clients reported experiences with side effects, 
yet many clients never discussed the possibility of side effects with a nurse and some 
clients discontinued the method. Further, few women discussed their HIV status or risk 
for HIV infection with nurses. In a population where women are at high risk for HIV 
infection or are likely to be HIV infected, it is imperative that nurses discuss HIV with 
every client.  
 Lack of information on the part of nurses and clients about contraceptive initiation 
and methods creates unnecessary barriers to post-partum contraceptive use in this 
population. Nurses require that patients are menstruating to confirm that they are not 
pregnant in order to initiate them on contraceptives.  This creates an unnecessary barrier 
to post-partum contraceptive use and requires women to return for multiple visits, further 
overloading the public health clinic and increasing costs. Additionally, nurses promote 
Nuristerate to younger women and Depo-provera to older women, although there are no 
medical indications that one should be preferred over the other based on age (109, 112).  
Nuristerate requires more injections (every 2 months) than Depo-provera and therefore 
costs more (65).  Finally, clients are interested in sterilization but did not discuss this 
method with nurses. Nurses perceived that clients were not interested in sterilization and 
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are confused about the process for clients seeking sterilizations at a nearby hospital. 
Increasing client’s access to permanent methods would also alleviate overcrowding and 
reduce long-term costs.  
Utilizing mixed research methods in this dissertation I sought to understand how 
knowledge of HIV status, unwanted fertility experience and health facility factors affect 
women’s intent to use modern contraceptives and actual modern contraceptive use in the 
post-partum period.  In a population of women where the HIV prevalence exceeds 30% 
and unplanned pregnancies are high, women’s control over the timing, spacing and 
limiting of births is important for maternal and child health. The South African 
government’s Prevention of Mother to Child Transmission of HIV program includes 
goals to reduce unwanted fertility in HIV positive women through modern contraceptive 
use. Findings from this dissertation indicate the PMTCT programs to reduce unwanted 
pregnancy in HIV positive women are succeeding in reaching them with messages about 
condom use and dual protection. However, PMTCT program managers must ensure that 
messages of condom use and dual protection reach HIV negative women as well. The 
measure of unwanted fertility experience likely underestimated unwanted fertility in this 
population. Further research is needed to understand unwanted versus mistimed 
pregnancies.  Mistimed pregnancies may be of more scientific importance because this 
population is highly contracepting, yet many pregnancies were reported as unplanned.  
The findings also indicate areas where PMTCT programs could improve post-partum 
contraceptive promotion to clients. Educating nurses about contraceptive initiation and 
more permanent methods, such as sterilization, could improve post-partum contraceptive 
use and reduce costs and patient overload. Creating opportunities for nurses and clients to 
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have more in-depth discussions about contraceptive methods, side effects, condoms and 
STIs would improve post-partum contraceptive use and continuation.  
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